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1 
Abstract 
 
Molecular biology's central dogma, laid down in 1950s, affirmed that genetic information 
flows from DNA to RNA to protein synthesis. For a long time, the first element of this logic 
scheme, DNA, was regarded as inactive molecule with the sole purpose to act as a repository 
of genetic code. Indeed, the molecular dialogue between DNA and proteins has been 
generally interpreted as an univocal relationship between an inert partner (nucleic acid) and 
a versatile one (proteins), that remodels DNA as a clay object. Rather, has been emerged 
that each kind of interactions between macromolecules requires a mutual structural 
adaptation and chemical complementarity. 
As in Kurosawa’s classic movie “Rashomon” (1950) the same central event, a heinous 
crime, is recalled from the differing perspective of each character (a bandit, a samurai, 
samurai’s wife and a woodcutter) this present study aims to highlight some different, but 
complementary, aspects of the full dynamic repertoire of DNA macromolecules. In the first 
part of this thesis, I will demonstrate that DNA, according to a peculiar three dimensional 
arrangement, is not only a simple recipe for proteins production but something more. In 
particular, I will focus on guanosine quadruplex structure, a not canonical B-form of DNA 
could be described through multiple points of view. 
On one side, synthetic guanosine quadruplex can act as “smart” biomolecules able to 
recognize multiple targets, with potential implications both as diagnostic as well as 
therapeutic agent. This short DNA/RNA sequences, called aptamers, according to a unique 
molecular flexibility, are able to recognize and bind a broad range of targets with 
specificities reminiscent those exhibited by antibodies. As working model, here I will 
present a detailed characterization in vitro of not physiological guanosine rich sequences 
able to bind human thrombin, a protein of physiological and pathological relevance. Our 
research was aimed to describe the relative role of the structural modules composing their 
molecular architecture. This allowed us to propose a structure activity relationship of 
synthetic G quadruplex aptamers, in order to fully rationalize and optimize their binding 
property. 
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On the other side, G-quadruplex forming sequences are also found in human genome. Some 
of them have been described as unique biochemical on/off switch able to regulate 
tumorigenic pathways. 
In particular, the expression of the oncogene c-Myc is controlled through the formation of 
non–B-form DNA structures within its promoter. The conformational shift of this promoter 
between a transcription inactive form (G-quadruplex form) to an active one (a canonical 
double strand form) is strictly regulated by several nuclear proteins. In the second section 
I’ll present a study concerning the heterologous expression, the purification scheme of the 
resulting products and the biochemical characterization of the functional domains of human 
nucleolin, a nucleolar protein that is able to inhibit c-Myc oncogene transcription by a 
peculiar recognition of its promoter in a G quadruplex form. This approach was pursued to 
deeper clarify the mechanism of this binding event. Doubtless, this represents a promising 
goal in order to develop new selective and effective chemotherapy drugs. 
Although revolutionary, the idea that genetic information was encoded only by DNA 
sequence, in a protein-free mechanism has been appeared definitely too simplistic. Indeed, 
in organisms with nuclei chromosomal DNA is organized along with protein templates 
(histones), forming a complex called chromatin. This is target of diverse array of 
posttranslational modifications that modulate the interaction among chromatin-associated 
proteins, which ultimately dictate dynamic transitions between transcriptionally active 
(euchromatin) or transcriptionally silent chromatin states (heterochromatin). In the last 
section, I will focus on the structural insights standing on the recognition event between a 
modified histone N-terminal tail and a specialized ‘effector’ protein (ORC1b), generally 
known for its role in pre-replication complex assembly. 
The identification of the molecular details that clarify how distinct protein modules are able 
to recognize specific histone modifications is a critical step to understanding how chromatin 
dynamics influence fundamental DNA-templated processes such as transcription, DNA 
recombination and DNA repair. In particular, our results identify the tandem PHD-BAH 
domains of Arabidopsis thaliana ORC1b as a novel unmethylated-lysine-binding module, 
thereby establishing the first direct link between histone methylation grade and the 
epigenetic role of ORC1b, previously known as a transcriptional regulation factor only for a 
series of specific interactions with silencing regulators. 
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Riassunto 
 
Il dogma fondante della biologia molecolare afferma che le informazioni genetiche sono 
decodificate attraverso un ordinato flusso logico, che parte dal DNA e passando attraverso il 
RNA arriva alla sintesi proteica. Per lungo tempo, all’interno di questo assunto, il DNA è 
stato esclusivamente considerato come il deposito biochimico delle informazioni genetiche. 
Con un ottica totalmente differente, in questo lavoro di tesi di dottorato presenterò tre 
aspetti, differenti ma complementari dell’intero repertorio funzionale del DNA.  
La prima sezione di questa tesi è rivolta ad un dettagliato studio degli aptameri leganti la 
trombina, ovvero sequenze non fisiologiche di DNA capaci di riconoscere selettivamente il 
target proteico in funzione di una specifica conformazione formata da quartetti di 
polideossiguanosine. Mediante una precisa caratterizzazione biofisica dei polimorfismi 
strutturali e dei profili di legame abbiamo potuto proporre delle solide ipotesi sul ruolo degli 
elementi modulari che ne compongono l’architettura molecolare, al fine di razionalizzare ed 
eventualmente incrementarne la capacità di riconoscimento del substrato proteico. 
Diversamente, porzioni di DNA capaci di autoassemblarsi in quartetti di guanosina sono 
state identificate all’interno del genoma umano. Alcune tra queste sono state descritte come 
straordinari interruttori biochimici capaci di regolare i processi tumorali. Nello specifico, 
l’espressione dell’oncogene c-Myc è fortemente controllata attraverso la formazione di 
strutture di DNA non canoniche all’interno del suo promotore. 
Questo equilibrio conformazionale del promotore tra una forma inattiva trascrizionalmente 
(struttura a quartetti di guanosina) ed una attiva (la canonica forma a doppia elica) è assistito 
e modulato da svariate proteine nucleari. Nella seconda parte del mio lavoro di tesi 
presenterò uno studio inerente all’espressione eterologa, la purificazione proteica del 
prodotto ricombinante e la caratterizzazione biochimica dei domini funzionali della 
nucleolina umana, una proteina nucleolare capace di inibire la trascrizione dell’oncogene c-
Myc attraverso un peculiare riconoscimento del suo promotore nella sua forma silente. 
Questo approccio è stato perseguito al fine di porre le prime basi per l’identificazione del 
meccanismo di riconoscimento proteina – DNA, fortemente implicato nella soppressione 
tumorale. 
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Anche se rivoluzionaria, l’idea che le informazioni genetiche siano codificate solamente 
all’interno della sequenza del DNA, secondo un meccanismo che contempla le proteine solo 
come “lettori” di questo codice, appare un concetto decisamente desueto. Il DNA 
cromosomiale, infatti, è organizzato su strutture proteiche (istoni) per le quali è stato esclusa 
una funzione esclusivamente “strutturale”. E’ stato dimostrato, infatti, che tali proteine sono 
soggette ad una serie di modifiche post trasduzionali che regolano attivamente l’attivazione 
e l’inibizione della trascrizione del DNA. Nell’ultima sezione presenterò uno studio 
finalizzato a chiarire i dettagli molecolari del riconoscimento tra un frammento istonico e i 
domini funzionali dell’effettore atORC1b (origin recognition complex 1b di arabidopsis 
thaliana).  
L’identificazione dei meccanismi molecolari mediante i quali distinti moduli proteici 
riconoscono le specifiche modificazioni istoniche rappresenta un passaggio chiave nella 
comprensione di fondamentali processi cellulari come la trascrizione, la ricombinazione 
cromosomiale e la riparazione del DNA. 
Nello specifico, il nostro studio ha evidenziato come i domini PHD e BAH dell’ORC1b, 
opportunamente combinati, possono agire come moduli di lettura del frammento N-
terminale dell’istone 3 nella sua specifica forma non metilata. 
Tale evidenza, per la prima volta, dimostra una correlazione diretta tra il grado di 
metilazione dell’istone e il ruolo epigenetico dell’ORC1b, precedentemente noto come 
regolatore indiretto della trascrizione solamente in funzione di interazione specifiche con 
fattori eterocromatinici. 
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1. Overview 
 
1.1 Fundamentals of quadruplex structures 
 
More than four decades before Watson and Crick proposed their structure for double helix 
DNA [1] it had been known that guanosine derivates at millimolar concentrations forms 
viscous gels in water. However it was only when the first X-ray diffraction data of 5’-
guanosine monophosphate gels was available (around fifteen years later) that this peculiar 
behaviour could be explained. [2] 
The three dimensional model shown that hydrogen-bonded tetramers of 5’-GMP were the 
molecular basis for the gel formation phenomenon. This non canonical DNA arrangement, 
adopted also by guanosine-rich DNA or RNA strands, was called Guanosine quadruplexes 
(G4s). (Fig. 1.1)  
 
 
Fig 1.1. Structure of intramolecular G-quadruplexes formed by the human c-Myc promoter 
sequence in K
+
 solution. (pdb entry: 2LBY) [3] 
6 
A G-quadruplex structure is formed by stacking of two or more guanine tetrads (or G-
tetrads), each of which made of four guanines assembled in a planar array stabilized by a 
cyclic Hoogsteen hydrogen bonding network that involves N1, N7, O6 and N2 of each 
guanine nucleobase (Fig. 1.2). [4-7] The formation of these structures requires the presence 
of metal ions, especially alkali metals. The ions are placed in the central cavity between the 
stacked quartets and they are coordinated by the electronegative carbonyl groups (O6) of 
guanines, which point towards the core of G-tetrads. In particular, the coordination of 
potassium, sodium and strontium adds both thermodynamically and kinetically to the 
stability of G-quadruplexes structure.[8] 
However, a number of other cations are also known to promote G-quadruplex formation. 
It has been proved that G-quadruplexes are stabilized by the alkali series in the following 
order: K
+
>>Na
+
>Rb
+
>Cs
+
>>Li
+
, and by the earth alkali series in the order: 
Sr
2+
>>Ba
2+
>Ca
2+
>Mg
2+
, indicating that the atomic radii of potassium and strontium 
(approximately 1.3 Å atomic radii) best fit in the coordination site between adjacent G-
tetrads. This property also defines the location of the cation with reference to the quartet 
plane. [9] 
Indeed, the larger potassium ion has been always found lied between stacked tetrads, almost 
equidistant from the eight oxygen atoms, whereas the smaller sodium ion (approximately 
1.18 Å atomic radii) can sit in the plane formed by guanosines. 
Nonetheless, one should remember that in live systems, where the G-quadruplexes are 
supposed to play a biological role, the free cations are dominated by few species whose 
approximate concentrations can dramatically vary of several order of magnitude depending 
on the biological district. ( e.g. K
+
 presents a concentration of 150 mM and 5.5 mM in intra- 
and extra- cellular environment, respectively). 
This wide range of conditions should be taken into account since each specific ionic strength 
environment could tune the G-quadruplex folding in a specific way. 
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Fig 1.2. Overall view of guanine tetrad. 
The guanine tetrad motif and its hydrogen bonding scheme reveal the hollow center that can 
accommodate the positive charged metal. 
Hoogsteen hydrogen bonding network is shown as orange dotted line. 
 
 
1.2 Structural diversity 
 
Despite an unifying definition, the most intriguing aspect of G-quadruplexes is their 
extensive polymorphism in spatial arrangement, which can be influenced by several 
structural features such as the number of strands involved, chain polarity, number of stacked 
tetrads, variation of the glycosidic torsion angle and loops arrangement. [4, 10] This 
structural polymorphism is dependent on the nucleic acid sequence (chain length, number of 
guanosine tracts, loops length and composition, etc) and could be tuned by different counter 
ions, the presence of binding partners and by the annealing conditions [11]. Quadruplexes 
can be formed by one, two or four DNA or RNA strands giving a broad range of possible 
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combinations. (Fig. 1.4) This is referred to as strand stoichiometry and it can be sub-divided 
in two groups, intermolecular (tetrameric (Fig. 1.4.a) or dimeric (Fig. 1.4.b)) or 
intramolecular (monomeric (Fig. 1.4.c))  quadruplexes. Another source of structural 
variability is the relative polarity direction of adjacent backbones. Irrespective of whether 
they are part of the same molecule or not, the strands that constitute a G-quadruplex can 
come together in four different ways. They can be all parallel (Fig. 1.4.a), three parallel and 
one antiparallel (Fig. 1.5.d), adjacent parallel (Fig. 1.5.b), or alternating antiparallel 
(Fig.1.5.a). Lately, in dimeric and monomeric G-quadruplexes, the nucleotide linkers 
between guanosines involved in G-quartet can adopt a wide range of arrangement. These 
loops can be classified into four major families: diagonal loops connecting two opposing 
antiparallel strands (fig. 1.5.b), edgewise loops connecting two adjacent antiparallel strands 
(fig. 1.5.a) and double-chain-reversal loops connecting adjacent parallel strands. (Fig. 1.5.c) 
[12] The types of loops depend strongly on the size [13] and composition of the linkers. [14] 
Diagonal loops can contain three or more residues. Instead, edgewise loops were observed to 
contain at least two residues. Ultimately, double-chain-reversal loops were observed to 
bridge two or three G-tetrad layers and contain from one to six residues.  
In the matter of this structural issue Hazel et al [15] conducted a detailed and comparative 
study of guanosine rich sequences defined by various loop lengths. He showed that 
quadruplex formation could occur with sequences containing up to seven nucleobases in the 
loops and accented how an increased number of bases decreased the stability of the 
structure. They further demonstrated, using both molecular modeling and biophysics, that 
very short loops (especially single-nucleobase loops) tend to promote a parallel 
quadruplexes by a guanosine rich sequence, whereas longer loops favor anti-parallel 
quadruplexes. Unpaired nucleobases, of the flexible loops, are able to form stacking 
interactions with the guanine tetrad adjacent to the loop, joining the interaction network that 
defines the thermodynamic properties of the entire structure. 
For instance, X-ray crystal structure of Oxytricha nova telomeric sequence (5’- 
GGGGTTTTGGGG -3’) fully evidences how thymine residues in the loops are involved in 
stabilizing π-stacking interactions with external G-tetrad (Fig. 1.3). [16] 
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.  
Fig 1.3. Crystal structure of the Oxytricha telomeric DNA (pdb code: 1JPQ) [16] at 1.6 Å. 
Thymidine residues (evidenced in grey) in the loop promote a stabilization of the guanosines 
forming the G tetrad. 
 
No rigorous rules or algorithms are able to predict quadruplex fold for a given 
oligonucleotidic sequence, and several examples of oligonucleotides that fold in different 
structures are reported in literature. In particular, it has been observed that a crucial role in 
determining three-dimensional structure is played by metal ions or molecular crowding 
agents. [9] For example, the folding topology of guanosine rich human telomeric DNA 
sequence in K
+
 solution is different from that in Na
+
 solution [17, 18], while the equivalent 
Oxytricha telomeric sequence adopts the same fold in the presence of either K
+
 or Na
+
 
cations. [16] 
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Fig.1.4: Various strand stoichiometries of G-quadruplex structures. 
 
(a) Four separate strands produce a tetrameric G-quadruplex. 
The structure of the parallel-stranded tetraplex formed by the hexanucleotide 
d[TG4T] in a Na
+
-containing crystal. (pdb entry: 244D) [19] 
 
(b) Two strands give a dimeric G-quadruplex 
Crystal structure of the potassium form of the Oxytricha nova telomeric sequence 
d[GGGGTTTTGGGG].(pdb entry: 1JPQ) [16] 
 
(c) A one-stranded structure yields a intramolecular G-quadruplex. 
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Fig.1.5: Different strand connectivity for intramolecular guanine tetrad structures. 
 
(a) All three loops run edgewise and connect adjacent-adjacent-adjacent strands. 
Structure of the 15mer thrombin binding aptamer d[GGTTGGTGTGGTTGG] in K
+
 
solution. (pdb entry: 148D) [20] 
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(b) One diagonal and two edgewise loops that connect adjacent-diagonal-adjacent 
strands. Structure adopted by the human telomeric sequence d[AGGG(TTAGGG)3] 
in Na
+
 solution.(pdb entry: 143D) [21] 
 
(c) All three double chain reversal loops that connect adjacent-adjacent-adjacent 
strands. 
Structure adopted by the human telomeric sequence d[AGGG(TTAGGG)3] in a K
+
-
containing crystal. (pdb entry: 1KF1) [22] 
 
(d) One double chain reversal and two edgewise loops that connect adjacent-
adjacent-adjacent strands. Structure of the hybrid-1 type intramolecular G-
quadruplex formed by a 26-nt sequence d[AAAGGG(TTAGGG)3AA] that contains 
the wild-type 22-nt four-G-tract human telomeric core sequence with modified 
flanking sequences in K
+
 solution. (pdb entry: 2HY9) [23] 
 
 
1.3 Biological interest on G-Quadruplexes 
 
The scientific interest on these non-canonical DNA forms has been ignited since it has been 
demonstrated that guanosine rich motifs are widely dispersed in eukaryotic genomes. [24-
26] Genome-wide sequence analyses using G-quadruplex signature sequences have revealed 
important information on the occurrence and location of potential quadruplex sequences 
(PQS). [27] Both prokaryotic and eukaryotic genomes from yeast to human are rich in 
PQSs. The human genome, for instance, contains as many as 376 000 PQSs. [27] Although 
the occurrence of PQSs in genomes is a third less than expected by chance, their location is 
non-random and seems to correlate with functional genomic domains. 
However although as many guanosine rich nucleic acid sequences are capable of forming G-
quadruplexes in vitro, one wonders how these structures could be plausible within cells.[28] 
The first direct evidence for the presence of G-quadruplex DNA structures in vivo came 
from studies performed with antibodies devoided to detect intermolecular G-quadruplex 
structures at ciliate telomeres.[29] These genomic segments, are located at the ends of 
chromosomes, consist of double stranded G-rich stretches repetitions (e.g. 5’-TTAGGG-3’ 
in humans and 5’-TTTTGGGG-3’ in Oxytricha) ending with a 3’ overhang at the G-rich 
strand. They have propensity to form G-quadruplex structures.[30] In somatic cells at each 
cellular replication telomere shortening occurs and this is used to define life of healthy cell 
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[31]. This shortening can be compensated by the synthesis of the repeat sequences at the 3‘ 
end of the chromosomes by the ribonucleoprotein telomerase. Such an activity is involved in 
the immortalization of tumor cells. Formation of G-quadruplexes at telomere ends could, in 
principle, prevent extension of 3’ overhangs and consequently suppress immortality of 
cancer cells. This hypothesis, primarily, has triggered the interest on G-quadruplexes, as 
important chemotherapeutic target, stimulating great effort in the study of small molecules 
that lead to their stabilization.[32] 
One other piece of evidence, for G-quadruplex formation in physiological conditions, comes 
by the detection of proteins with significant biological activities, such as helicases and 
nucleases, which bind specifically to this peculiar structures. [33] 
Finally, a significant developments occurred in 2002 when Hurley and co-workers [34] 
reported in vivo evidence for the structure and function of G-quadruplex in a gene-promoter 
region within human cells. This intramolecular G-quadruplex, made up of a 20–30 base-pair 
region, was specifically targeted and stabilized by a specific G-quadruplex binder small 
molecule, which resulted in transcription repression of the c-Myc oncogenic protein. [35] 
In nature, putative G-quadruplex forming sequences were found also in other regions of 
biological interest such as in the immunoglobulin switch regions, upstream of the insulin 
gene, in the retinoblastoma susceptibility gene and prominently in the promoter regions of 
oncogenes, such as c-Kit, HIF-1α, Rb, BCL-2, VEGF, H-Ras, N-Ras, K-Ras and RET. [36] 
All those findings suggest that G-quadruplex DNA may play a central role in several 
biological events, such as telomere maintenance, telomere capping, replication fork 
progression, chromosome organization, regulation of gene expression and recombination 
that immunoglobulin heavy chains undergo to bring different constant regions next to 
variable regions during the differentiation of B lymphocytes. [26] In addition, severe 
pathological conditions like cancer, fragile X syndrome, bloom syndrome, Werner syndrome 
and Fanconi anemia are related to genomic defects that involve G-quadruplex forming 
sequences. [24, 37, 38] Although an extensive biological involvement of G4 structures, the 
interest on those non-canonical DNA forms cannot be run out without considering their 
further role in a plethora of areas ranging from structural biology and supramolecular 
chemistry to nanotechnology and medicinal chemistry [39, 40]. For example, in regard of 
this last branch, some artificial G-rich oligomer sequences, capable to build G-quadruplexes, 
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possess interesting biological activities, such as anticoagulant, anticancer and anti-HIV 
agents. [40] 
 
 
1.4 Aptamers 
 
The use of nucleic acids as drugs represents a consistently growing approach. Different 
therapeutical strategies take advantage of the biological and biophysical properties of DNA 
and RNA to properly modulate activity of selected targets. During the last twenty years, this 
has led to the theoretical and experimental development of oligonucleotide aptamers. 
Aptamers are not physiologic DNA- or RNA-based oligonucleotides (with a molecular 
weight of 5–26 kDa), which are able to recognize with high affinity and specificity a wide 
range of natural and synthetic targets such as small organic molecules, peptides, proteins and 
even cells. [41-43] 
This target versatility is achieved by their structural flexibility which allows them to assume 
distinct folding depending upon their sequence and/or environment. [44] These 
oligonucleotides are normally selected by a powerful combinatorial and iterative 
methodology, called SELEX (Systematic Evolution of Ligands by EXponential enrichment), 
which fishes out, from an oligonucleotide random pool, the ligands which show high affinity 
to a desired target.[45] Accordingly, aptamers demonstrated a wide range of applications not 
only in therapeutic but also in analytical and clinical diagnostic fields.  
They are object of interest for several reasons: 
 Aptamers are important as novel bio-recognition elements, evidencing a wide 
versatility in affinity sensing applications, as immobilised ligands or in homogeneous 
assays. The use of aptamers as bio-transducers brought to the development of 
acoustic and optical sensors, cantilever-based biosensors and diagnostic tools. [46-
48] 
 
 DNA/RNA aptamers may themselves act as therapeutics, with potential applications 
as anticoagulants, antivirals, antirheumatics and antiproliferative agents. For 
instance, the first RNA aptamer based drug, Macugen (Pegaptanib sodium) has been 
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approved by the US FDA in December 2004. This nucleic acid based drug is been 
currently used for patients affected by age-related macular degeneration (AMD), a 
pathology which induces a progressive loss of visual acuity due to an aberrant 
regulation of angiogenesis. [49] 
 
 Finally, aptamers represent interesting DNA/RNA model systems to investigate bio 
macromolecular recognition. 
 
 In 2004 Breaker et al. first provided the evidence that also inside the cell we can find 
some examples of physiological “aptamers”. Those structures are RNA regulatory 
elements called riboswitches where the plastic structure of specific polynucleotides 
ensures high affinity toward small metabolites. [50] 
 
Although guanosine quadruplex structures is not a conditio sine qua non for DNA aptamer 
architecture, representing just one of several possible options of folding adopted, a 
conspicuous number of G4-based aptamers are reported in literature. This finding highlights 
the role of this peculiar structure in target-DNA recognition.[51] 
Compared to conventional drugs, aptamers can be theoretically used in any disease for 
which blockade of pathogenic protein–protein interactions is required, either with an 
inhibition effect (for example, aptamer against HER3 [52]) or with an agonistic-like action 
(e.g., DNA aptamer to isoleucyl tRNA synthetase [53]). Aptamers possess several 
advantages over other therapeutic agents such as monoclonal antibodies. First, production of 
aptamers does not rely on biological systems since they are produced chemically in a readily 
scalable process with low batch-to-batch variability. Second, aptamers are quite thermally 
stable and can be denatured and renatured multiple times without significant loss of activity. 
Third, aptamers do not show a remarkable immune response and their activity can be easily 
controlled by the addiction of complementary DNA-RNA strands, controlling agents which 
selectively bind and neutralize the active oligonucleotides. [54] Lastly, conjugation 
chemistry for the attachment of various imaging labels or functional groups to aptamers are 
orthogonal to nucleic acid chemistry, hence they can be easily introduced during aptamer 
synthesis. On reverse, the main drawbacks related to the use of DNA aptamers as 
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therapeutics include a potentially weaker binding to targets than antibodies, unpredictable 
toxicity and a poor pharmacokinetic profile given by their susceptibility to serum 
degradation and by a faster excretion than antibodies due to smaller size and a generally 
higher hydrophilicity. The nuclease-mediated degradation can be easily overcome by 
introducing chemical modifications on the nucleoside’s scaffold, for example at the 
phosphoribose backbone (as 2′-deoxy-2’-amino pyrimidines, 2′-fluoro pyrimidines and 2′-O-
methyl ribose purines and pyrimidines) or at nucleobases (for example, at 5-position of 
uridine) and by inserting not natural inter-nucleotide linkages such as phosphorothioate 
linkages (Fig. 1.6). 
Conversely, to overcome the problem of bioavailability and thus reduce the rates of renal 
filtration several strategies have been proposed, such as attacking high molecular mass 
polyethylene glycol (PEG) or cholesterol at the 5′-terminus. [41] 
The previous optimization strategies are aimed at ensuring enhanced accessibility of tailor-
made aptamers for use in specific applications, where the unique properties of aptamers can 
be taken be taken advantage of. 
 
 
Fig. 1.6: Examples of modified nucleotides used to reduce nucleic acid degradation by 
nucleases. 
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1.5 Thrombin 
 
Although, there are no scientific evidences that thrombin physiologically interacts with 
nucleic acids, its remarkable spectrum of biological activities made it one of the first 
biological macromolecule selected for the development of specific aptamers via SELEX. 
[55] 
Thrombin is a multifunctional serine protease that plays a pivotal role in the coagulation 
cascade and in wound healing by exerting two important and paradoxically opposing 
functions. [56, 57] 
It acts as a procoagulant factor when it cleaves soluble fibrinogen into insoluble 
polymerogenic fibrin, the main constituent of blood clot. [58, 59] This function is reinforced 
and amplified by activation of coagulation factors produced by a thrombin-mediated 
cleavage. Relevant examples are: 
 the activating cleavage of tranglutaminase FXIII which stabilizes the nascent fibrin 
clot by crosslinking adjacent fibrin monomers through ε-(γ-glutamyl) lysine bonds. 
 the inhibition of fibrinolysis by the activation of thrombin-activated fibrinolysis 
inhibitor (TAFI). 
 the proteolytic feedback activation of the serine protease factor XI and the cofactors 
V and VIII. 
 In addition, in human, thrombin promotes platelets activation and aggregation by 
specific recognition and cleavage of protease activated receptors (PARs) 1 and 4, a 
member of seven transmembrane receptors. PAR1 is the primary thrombin substrate 
on platelets surface and picomolar thrombin concentrations are required for effective 
activation. Its action is reinforced by PAR4 whose activation occurs only at high 
thrombin concentrations (>10 nM). [59] 
Besides procoagulant stimuli, thrombin can also promote an anticoagulant response through 
activation of protein C. This property results under the allosteric control of the cofactor 
thrombomodulin, a receptor on the membrane of endothelial cells. [58] 
Upon binding to thrombomodulin, the ability of thrombin to cleave fibrinogen and PAR1 is 
suppressed, but its recognition for the zymogen protein C increases >1000-fold. 
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Upon thrombin-mediated clavage protein C is activated in this form. It attenuates the 
coagulant pathway by cleaving factors Va and VIIIa and by down-regulating the two 
cofactors Xa and IXa, which are required for thrombin generation, thereby shooting down 
the blood coagulation system. 
Moreover, thrombin downregulation and clearance in plasma can also be achieved by 
irreversibly inactivation via the serine protease inhibitors (serpin), such as antithrombin III 
with the assistance of heparin, the thrombin-specific heparin cofactor II (HCII) and protease 
nexin I (PNI).  
The pharmacological complexity of the “living enzyme of my blood”, as thrombin was 
defined by Walter Seeger [60], could not be reduced to a balance between procoagulant and 
anticoagulant properties. Indeed, it plays a crucial role at the interface between coagulation 
cascade, inflammation and cell proliferation. In addition, this protease has been implicated 
in angiogenesis, evidencing a role in the growth and in the metastatic diffusion of cancer as 
well as in the muscle development. 
Human α thrombin is generated from its inactive precursor, prothrombin (factor II), which is 
produced in the liver (normal human plasma concentration 5–10 mg/dL). Its activation 
requires the temporary formation of prothrombinase complex, composed by factors Va, Xa, 
Ca
2+
 and membrane phospholipids.[61] The resulting active protein is a dimer composed of 
a light polypeptide chain (A chain, 36 residues, MW ~6 kDA) and a heavy chain (B chain, 
259 residues, MW ~31 kDa), covalently linked through a disulfide bond (Cys9-Cys119). 
(Fig. 1.7) [56] 
The B chain, which presents the typical serine protease fold, composed of two adjacent β-
barrels, carries the functional domains of the enzyme and accommodates the catalytic triad   
(histidine 57, aspartic acid 102 and serine 195) inside the active site cleft (Fig. 1.7). The 
walls of the active site are formed by the two loops (60-loop and γ-insertion loop), involved 
in restricting and regulating the access of substrates to the catalytic region. 
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Fig. 1.7: X-ray structure of human thrombin (pdb code: 1HUT [15]). Portions corresponding 
to heavy (yellow) and light (purple) chains are evidences. 
The catalytic triad in the active site was highlighted. 
 
Thrombin-binders recognition occurs at two positive charged patches, named exosite I and 
II, which are present on the surface of the protease in near-opposition with reference to the 
enzyme catalytic site. (Fig 1.8) The presence of these distinct functional epitopes on its 
surface allows a fine regulation of its catalytic functions by multiple interactions with 
substrates, inhibitors and effectors (Fig. 1.8). The exosite I is predominantly involved in the 
electrostatic steering of fibrinogen, thrombin physiological substrate, toward the cleavage 
site. Contemporaneously, it acts as binding domain for both procoagulant substrates (Factor 
V and VIII, PAR1 and 4) and potent inhibitors such as thrombomodulin, heparin cofactor II 
and hirudin. [62] Fewer ligands are directed toward exosite II. In accordance to the 
significant presence of positively charged residues on its surface, this is the protein domain 
that interacts with polyanionic macromolecules like glucosaminoglycans (GAGs), such as 
heparin, heparan sulphate and dermatan sulphate.[63] The interaction between these 
negative charged chains and thrombin is fully ionic in nature and is required to bridge 
antithrombin III (ATIII - the major physiological inhibitor of thrombin) to thrombin, thus 
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promoting the inhibition of the coagulation cascade. Exosite II is also the platform for 
thrombin interaction with platelet receptors GpIb and the γI fibrinogen chain. More recently, 
a role for the Na
+
 ion as allosteric modulator was evidenced.[64] This ion drives the enzyme 
from a slow activity form (Na
+
 free) to a fast activity form (Na
+ 
bound). The slow and fast 
forms are both significantly (2:3 ratio) populated under physiologic conditions because the 
Kd for Na
+
 binding is 110 mM at 37 °C and the [NaCl] concentration in the blood (140 mM) 
is not sufficient to saturate thrombin. The slow form shows an intrinsic anticoagulant nature, 
defined by a prolonged clotting time, a reduced platelet activation time and a higher 
specificity for protein C (the major component of the down regulation pathway of thrombin) 
in comparison to the natural substrate, the fibrinogen. On the opposite, the Na
+
 bound form 
shows procoagulant properties. This conformation shows an enhanced affinity for fibrinogen 
and protease platelet receptors (PARs), responsible for the promotion of platelets activation. 
 
Fig. 1.8: X-ray structure of human thrombin (pdb code: 1HUT [15]). Surfaces corresponding 
to exosite I and II are evidences. 
Surfaces charges are evidenced on the exosites surfaces (blue positive charges, red negative 
ones). 
Examples of site selective substrates, effectors and inhibitors with pro-coagulant (in bold) or 
anticoagulant (in italic) properties are indicated. 
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Thrombin generation is finely regulated to locally achieve rapid restoration of vascular 
integrity after injury, without causing aberrant systemic thrombosis. In the absences of 
efficient and timely controlled thrombin generation, stable blood clots cannot form, resulting 
in hemorrhage. Conversely, uncontrolled thrombin activity produces an excessive 
coagulation, resulting in dissemination of the clot beyond the site of vessel damage 
obstruction of normal blood flow. This causes thrombosis and related diseases, which are 
among the main causes of mortality in western countries. The capability of regulating the 
pathological activity of thrombin in vivo by synthetic compounds is an important goal in 
prevention and treatment of thrombovascular diseases. Anticoagulants include both indirect 
and direct inhibitors of thrombin enzyme.[65] The indirect inhibitors (Antithrombin 
dependent) act by favoring the binding of thrombin to SERPINs (SERine Protease 
INhibitors), which irreversibly suppress thrombin activity. This last mechanism is that by 
which heparin acts, binding thrombin at exosite II and promoting the formation of the 
complex between thrombin and a SERPIN, antithrombin. Such inhibitors are heparins 
(unfractionated heparin (UFH) and low-molecular-weight heparins (LWMHs)) and the 
synthetic pentasaccharide. Differently, the direct inhibitors (Antithrombin independent) 
interact with the procoagulant enzyme’s active site or an exosite blocking its protease 
activity. Direct inhibitors of coagulation being clinically tested include hirudin, hirulog, 
bivalirudin, argatroban, melagatran and the oral prodrug ximelagratan (H37695). This last 
category has several potential advantages over heparin: They can inhibit thrombin bound to 
clots or extracellular matrices, which are relatively resistant to heparin and do not require 
antithrombin III as a cofactor, which may lead to a more predictable dose response. Despite 
its phenomenal success, current anticoagulation therapy suffers from the risk toward serious 
bleeding, since exists a direct correlation between the intensity of anticoagulation action and 
severity of bleeding.  
Hence, the discovery of new molecules capable of modulating thrombin activity represents a 
compelling challenge for the development of more effective and safer anticoagulant 
strategies. 
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1.6 Thrombin binding aptamers 
 
An innovative drug-like scaffold used to target thrombin is represented by DNA. 
In particular, oligonucleotide aptamers have been ignited the attention of scientific 
community according to their thrombin recognition ability. 
The first identified thrombin binding aptamer was a 15-mer DNA selected with the iterative 
SELEX technique from a random pool of 60mers, the sequence of which is  
5'-GGTTGGTGTGGTTGG-3' (15fTBA, Fig. 1.9 ). [55] 
According to the behaviour of other G-rich sequences, in the presence of monovalent ions 
like K
+
 this sequence folds intramolecularly to adopt a G-quadruplex structure [66, 67]. This 
consists of two overlapped planes each deriving from the pairing of four guanines through 
reverse Hoogsteen hydrogen bonding (G-tetrads). In particular, as confirmed by NMR [20] 
and X-ray crystallography [68], this aptamer, in the presence of potassium ions, adopts an 
anti-parallel chair structure containing two G(syn)-G(anti)-G(syn)-G(anti) quartets and three 
lateral loops, two minor TT loops on one side and a major TGT loop on the opposite side 
(Fig. 1.9). [69, 70]. This highly ordered folding of the oligonucleotide is induced by 
thrombin as well, which acts as a chaperone prompting G-quadruplex formation also in the 
absence of stabilizing monovalent ions.[71, 72] 
Fig 1.9: (a) Schematic representation of 15mer thrombin binding aptamer (15fTBA). (b) The 
crystal structure of the intramolecular quadruplex formed by the 15mer thrombin binding 
aptamer (PDB entry: 148D). Overall topology is indicated by the ribbon representation in 
blue. The guanosines forming the two stacked tetrads are evidenced in black. 
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Despite the great importance of 15fTBA in diagnostic and therapeutic field for both 
detection and inhibition of α-thrombin. a clear picture of the structural insights describing 
the DNA-protein complex is still missing. A plausible but not controversial model 
describing the structure of the protein-aptamer complex has been solved, only recently, by 
X-ray diffraction [73]. The crystal structure confirms that the 15fTBA does not interact 
directly with the protein catalytic site. Otherwise, it preferentially recognizes the positively 
charged exosite I with the two shorter TT loops, largely through salt bridges. Conversely, 
the major TGT loop is not involved in thrombin binding and only marginally participates to 
the binding through not specific stabilizing interactions. 
Ionic and hydrophobic interactions occur at protein-DNA binding interface. In details, a 
stabilizing electrostatic network involves the protein residues Arg 75, Glu 77, Asn 78 and 
Tyr 117. (Fig. 1.10) 
Conversely, tyrosine 76 and isoleucine 79 interact with minor loop nucleobases via 
hydrophobic interactions. (Fig. 1.10) 
 
 
Fig 1.10: Representation of the crystallographic proposed models of thrombin-TBA 
complex (pdb entry: 4DII). [73] Thrombin molecule is shown as cartoon with heavy chain in 
yellow and light chain in violet. 15fTBA is shown in blue cartoon. Residues involved in the 
binding are evidenced. 
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In 1997 Tasset et al [74] isolated a 29-residues DNA aptamer which showed an incremented 
binding affinity for human thrombin. It presents the sequence: 5’- 
AGTCCGTGGTAGGGCAGGTTGGGGTGACT -3’ (29hTBA). The underlined sequence 
corresponds to a 15-nucleotide core (15hTBA) which clearly remember the 15fTBA. 
Distinctly from 15fTBA, 29hTBA contains a 5’ and 3’ terminal chains that can form a 
Watson Crick duplex connected by two 3-base bulges to a 15-mer G-quadruplex core to 
produce a quadruplex/duplex mixed structure. (Fig. 1.11) Although, no structural 
information concerning this aptamer is available. It was supposed that the G-quadruplex 
conformation of the aptamers could be functional to properly display the loops, which were 
considered involved in selection of aptamer-protein interactions. 
Interestingly, for this sequence emerged a peculiar thrombin binding selectivity (described 
in a conspicuous number of scientific works), directed toward heparin binding exosite 
(exosite II).[74] 
 
Fig. 1.11: Schematic representation of 29mer thrombin binding aptamer (29hTBA). 
 
Upon protein binding both aptamers inhibit thrombin-catalyzed fibrin clot formation in 
vitro, thus they are equally relevant from a pharmacological point of view. Nevertheless, the 
molecular mechanisms leading to the biological activity presumably is distinct. Clinical 
applications of the above aptamer sequences are hampered by their extremely short in vivo 
half-life. [75, 76] Several modifications can be introduced to overcome this poor 
pharmacokinetic profile. [77, 78] However, to rationally design drug candidates without 
altering aptamers-protein recognition profile, molecular details of the binding process need 
to be fully clarified. 
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2. Folding versus charge: understanding selective target recognition by 
the thrombin aptamers 
 
2.1 Introduction 
 
The formation of the complex between thrombin binding aptamers and their biological 
target is the result of complementarities between the two macromolecules promoted by the 
aptamer sequence (the sequence length and the composition) and folding as well as of 
electrostatic interactions generated by the charge balance on the interaction surfaces. Thus, 
modest chemical modification in crucial structural elements can largely impair the biological 
response. In order to rationally design aptamer candidates for clinical applications without 
altering aptamers-protein recognition profile a precise study of molecular details of the 
binding process need to be carried out. 
For example, how can we identify the driving elements that produce an efficient and 
selective binding? How can we effectively combine the contribution of the three-
dimensional structure, the sequence length and composition, the role of the anionic 
phosphate backbone? To properly approach these questions and, thus, to better describe the 
mechanism of the DNA-protein interactions at molecular level we choose to study and 
compare the behaviour of several polydeoxynucleotides. Firstly, we widely investigated the 
conformational properties and the binding ability of the reference aptameric sequence 
15fTBA and the multi-domains 29hTBA, to properly define an occurring correlation 
between a peculiar folding adopted in solution and the capability to specifically recognize 
the protein target. Within the 29hTBA sequence we identify and study the corresponding 
guanosine rich core 15hTBA, in order to clarify if a simpler structure respect the 29hTBA 
still maintains a peculiar binding ability.  
Once we obtained an overall picture describing the correlation between the binding affinity 
and the folding features of the thrombin binding aptamers we started to focus our attention 
on linear DNA sequences, which do not present an ordered structure. The 
polydeoxynucleotides were opportunely designed with a different chain length and 
composition in order to explore the electrostatic contribution and the role of nucleobase 
composition on the binding event. 
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15fTBA 
29hTBA 
15hTBA 
(dT)10 
(dT)20 
(dT)40 
(dT)60 
(dT)80 
(dA)40 
(dC)40 
(dGT)20 
(dAC)20 
5’- GGTTGGTGTGGTTGG -3’ 
5’- AGTCCGTGGTAGGGCAGGTTGGGGTGACT -3’ 
5’- GGTAGGGCAGGTTGG -3’ 
5’- [T]n -3’  where n = 10 
5’- [T]n -3’  where n = 20 
5’- [T]n -3’  where n = 40 
5’- [T]n -3’  where n = 60 
5’- [T]n -3’  where n = 80 
5’- [A]n -3’  where n = 40 
5’- [C]n -3’  where n = 40 
5’- [GT]n -3’  where n = 20 
5’- [AC]n -3’  where n = 20 
 
Table 2.1: Sequences reported for oligonucleotides studied.  
 
By comparing their thrombin binding and inhibition properties and by mapping their 
preferentially recognized binding sites, we aimed to hierarchically define the contribution of 
sequence, structure and ionic interactions in TBAs-thrombin binding event. 
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2.2 Materials and methods 
 
2.2.1 Materials 
 
Proteins. Human thrombin was supplied by Sigma Aldrich (St Louis, Missouri, USA) as 
lyophilized powder solubilized in MilliQ
®
 water at a final concentration of 27 μM and then 
stored at -80 °C. The colorimetric thrombin substrate (Benzoyl-Phe-Val-Arg-pNA) was 
purchased from Calbiochem as lyophilized powder, solubilized in MilliQ
®
 water at a final 
concentration of 1 mg/ml and then stored at -20 °C. 
 
Synthetic oligonucleotides. HPLC purified oligonucleotides as well as their labelled forms 
(3' FAM and 5’-Dabcyl) were purchased from Eurogentec (Serain, Belgium) as lyophilized 
powder and solubilized in 10 mM Tris, 1 mM EDTA, pH 7.4. Oligonucleotide concentration 
was determined by absorbance at 260 nm. Before each experiment, DNA solutions were 
heated at 95°C for 5 minutes and slowly cooled at room temperature overnight in the 
required buffer 
 
2.2.2 Methods 
 
Circular dichroism (CD). Circular dichroism spectra from 220 to 320 nm were recorded 
using 10 mm path length cells on a Jasco J 810 spectropolarimeter equipped with a 
NESLAB temperature controller device to achieve constant temperature of 25 °C in a quartz 
cell with 
optical path length of 1 cm. The reported spectrum of each sample represents the average of 
3 scans recorded with 1-nm step resolution. Observed ellipticities were converted to mean 
residue ellipticity [θ] = deg x cm2 x dmol-1 (Mol. Ellip.).  
Apparent binding constant (Kd) for the G quadruplex stabilizing ions were calculated by 
fitting the relative variations of CD signal at 295 nm as a function of the corresponding 
potassium concentration. The relative variations of CD signal were obtained as Δθ/Δθmax and 
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the data were elaborated using the data analysis module of Sigma Plot (Systat Software Inc.) 
accordingly to a single binding model. 
The melting curves were acquired recording the CD signal at 295 nm while applying a 
heating rate of 1°C/min. Tm values were obtained from the minima in the first derivatives of 
the melting profiles using the Jasco software. 
The buffers used for the CD experiments contained 10 mM Tris-HCl at pH 7.4 in addition to 
the indicated levels of KCl. Solutions were titrated with the concentrated KCl solution (3 
M), by stepwise addition of 2–5 μl aliquots until no further changes in spectrum took place. 
 
Electrophoretic Mobility Shift Assay (EMSA). DNA (1 μM) was incubated with 
increasing protein concentrations (0-11 μM) for 30 minutes at room temperature in 10 mM 
Tris, 50 mM KCl, pH 7.4. Then the reaction mixture was loaded onto a 12% native 
polyacrylamide gel (acrylamide : bisacrylamide 19:1) in 1X TBE buffer (89 mM Tris, 89 
mM boric acid and 2 mM Na2EDTA) added of 10 mM KCl. Gels were stained with 
GelRed® or SybrGreen II® and visualized on a Geliance 600 (Perkin Elmer) 
 
Thrombin Inhibition assay. Chromogenic substrates for coagulation and fibrinolytic 
enzymes were developed in the early 1970s and very soon employed in assays for the 
determination of protein activity, by meaning of spectrophotometric techniques. 
A chromogenic substrate is a synthetic peptide, composed of 3-5 amino acids that mimics 
the cleavage site of the natural protein substrate and is functionalized at the end with the 
chromophore 4-nitroaniline (pNA). 
This method is based on differences in Uv-Vis absorbance between the chromogenic 
substrate and the released p-nitroanilide (pNA). 
The kinetics of thrombin proteolytic activity was measured by following the cleavage of the 
chromogenic substrate Benzoyl-Phe-Val-Arg-pNA in the presence/absence of increasing 
concentration of selected oligonucleotides (0-3 μM) in phosphate buffer (10 mM Na2HPO4 
,100 mM NaCl, 0.1% PEG8000, 0.1% BSA, pH 7.4). 
Upon cleavage, the polypeptide substrate releases p-nitroaniline that absorbs light at a 
wavelength of 405 nm. This allows to monitor the progression of the reaction. The 
absorbance at 405 nm was determined in a 96-well plate microplate reader set at 25 °C 
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(Victor 3 - Multilabel counter – Perkin Elmer). In a final volume reaction of 320 μl 72 μM 
of chromogenic substrate were added of human thrombin (4.5 nM) and incubated for 5 min 
at 25°C, then readings were taken every 5 min for a period of 45 min. The activity of the 
protease was determined from a slope of plots absorbance versus time as a function of 
increasing test oligonucleotides concentrations. 
 
Fluorescence quenching assay. Fluorescence quenching assay was performed in a Light 
Cycler 1.5 Fluorimeter (Roche) using λex 488 nm and λem 520 nm in LiP buffer (10 mM 
LiOH, 50 mM KCl, pH 7.4 with H3PO4). Aptamers thermal stabilities (0.5 μM) were 
recorded in the presence of increasing thrombin concentrations (0-5 μM) or by addition of 
competitors oligonuclotides (0-5 μM) in the presence of a constant thrombin concentration. 
Melting curves were recorded by increasing the temperature from 30 to 95 °C at a rate of 1 
°C/ min. followed by a final step in which temperature was maintained at 95 °C. Tm values 
were determined from the first derivatives of the melting profiles using the Roche 
LightCycler software. Each experiment was repeated at least three times and errors detected 
were ± 0.4°C. 
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2.3 Results 
 
2.3.1 Characterization of aptamer folding 
 
Circular dichroism spectroscopy (CD) is a leading technique used to gain information about 
protein and nucleic acid topology and to monitor conformational changes. [79-82] 
Guanosine-rich DNA sequence, such as thrombin binding aptamers, are known to adopt a 
specific conformation called G-quadruplexes. This conformation is characterized by a high 
polymorphism that can result from different strands polarity arrangements. 
Chain polarities constrain the chromophore guanosines to assume distinct orientations 
around the glycosidic bond. As a result, different CD patterns of the two quadruplexes forms 
are originated. [83] In particular, spectra relative to “parallel” quadruplexes are generally 
defined by a precise chiroptical “fingerprint” distinguished by a positive band at ca. 260 nm 
and a negative peak at ca. 240 nm, with a zero crossing at 250 nm.  Distinctly, the presence 
of a negative band at ca. 265 nm, a maximum at ca. 290 nm and a zero crossing at 280 nm 
are features of antiparallel quadruplexes spectra. [79] 
The two tested 15-mers oligonucleotides, 15fTBA and 15hTBA were reported to adopt an 
antiparallel conformation in the presence of K
+
 whereas it was suggested that the same 
monovalent ion promotes a parallel G-quadruplex conformation for 29hTBA [66, 84]. To 
better understand this issue, we performed a comparative analysis of G-quadruplex structure 
of 15fTBA, 15hTBA and 29hTBA by means of CD spectroscopy (Fig. 2.1). In the absence 
of monovalent cations all oligonucleotides showed distinct CD spectra (Fig. 2.1.C) that 
undergo remarkable changes upon addition of K
+ 
(Fig. 2.1.D). Generally, an increment of 
the band intensity around 290-295 nm is observed, suggesting the induction of an 
antiparallel G-quadruplex folding [85, 86]. As far as the shorter 15fTBA and 15hTBA, their 
CD spectra almost overlap in the presence of K
+
, which points to a very similar folded 
conformation (Fig. 2.1.D). However, 29hTBA exhibits a CD signature clearly distinct from 
the two 15-mers both in presence or absence of monovalent metal ions (Fig. 2.1.B). In 
particular, in the presence of K
+
, a reduced intensity of all dichroic bands is observed, which 
likely reflects the expected simultaneous presence of sequence segments involved in 
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different foldings. In this condition, a safe prediction of the G-quadruplex folding is not 
easy. 
Nevertheless, by subtracting the contribution of the G-quadruplex folded core (15hTBA) 
from 29hTBA (Fig. 2.1.E), we obtain a differential spectrum largely corresponding to those 
of a linear DNA (a positive band at 275 and a negative one at 250). This can reasonably be 
attributed to the partially paired steam portion. Additionally if we subtract the spectra 
recorded in the presence and in the absence of K
+
 (Fig. 2.1.F), the tendency towards a G-
quadruplex structure clearly appears. Interestingly, the differential spectrum is very similar 
to the spectrum of 15hTBA, which strongly suggests the formation of a common 
(antiparallel) folding adopted by the corresponding 29mer and 15mer sequences. 
 
Fig. 2.1. In PANEL A, the variation of 15fTBA CD spectrum upon addition of KCl to the 
oligonucleotide previously annealed. The arrows indicate the variation induced by the 
increasing K
+
 concentrations (0-85 mM). 
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In PANEL B, the variation of 29hTBA CD spectrum upon addition of KCl to the 
oligonucleotide previously annealed. The arrows indicate the variation induced by the 
increasing K
+
 concentrations (0-150 mM). 
CD spectra of 15fTBA (red line), 29hTBA (purple line) and 15hTBA (light purple line) in 
the absence (PANEL C) or presence (PANEL D) of saturating concentrations of K
+
 ions.  
DNA concentration 5 µM in 10 mM Tris, pH 7.4. 
In PANEL E, the spectrum of 29hTBA subtracted of the 15hTBA at saturating K
+
 
concentrations is reported in a dashed line. 
In PANEL F, the spectrum of 29hTBA at saturating concentration of K
+
 ions subtracted of 
the 29hTBA in the absence of K
+
 ions is reported in a dotted line. 
 
Since the CD spectra recorded to monitor the structural conversion promoted by potassium 
ions showed isodichroic points for all tested oligonucleotides (Fig. 2.2.D), we analyzed 
isothermal titrations according to one binding event.  
The apparent dissociation constants obtained are reported in Table 2.2. Interestingly, the 
affinity for the monovalent metal ion is strikingly reduced (2 orders of magnitude) when a 
stem region is included in the sequence. 
Additionally, we monitored the temperature dependence of the CD signal at 293 nm, a 
wavelength at which we can follow the structural transitions of the G-quadruplex core 
irrespectively of the aptamers composition (Fig. 2.2.A).[87] In line with literature data we 
observed similar Tm values for 15fTBA and 15hTBA in 50 mM K
+
 [66, 86]. On the 
opposite, in the same experimental conditions, the 29-bases aptamer showed a significantly 
lower Tm that correlates with its lower affinity for the monovalent metal ion (Table 2.2). 
This behaviour appears peculiar since the presence of the double stranded portion should be 
expected to promote the G-quadruplex folding. However, we observed that in the absence of 
an annealing procedure before K
+
 addition, (thus likely in the absence of a correct pairing of 
the steam region), the subsequent addition of monovalent ion promotes the induction of a 
kinetically controlled form (it resembles the previously proposed parallel/mixed G-
quadruplex [84]). This structure slowly converts into the most thermodynamically favoured 
antiparallel G-quadruplex fold (Fig. 2.2.B). 
Hence, the stem nucleotides impairs G-quadruplex stability probably allows coexistence of 
multiple conformations in equilibrium through the unfolded form. In fact, annealing is 
required to allow direct formation of a G-quadruplex structure, common to all the tested 
sequences. 
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Fig. 2.2. In PANEL A, melting profiles of selected aptamers recorded monitoring the CD 
signal at 295 nm in 50 mM K
+
. 
In PANEL B, the variation of 29hTBA CD spectra upon addition of KCl to the 
oligonucleotide previously not annealed. PANEL B reports the CD spectra recorded in the 
absence of K
+
 (solid line), immediately after addition of 50 mM K
+
 (dotted line) or after 24 
hours of incubation (dashed line). 
 
 
 
 CD fluorescence 
 Kd (mM) Tm (°C) Tm (°C) 
15fTBA 0.41 ± 0.17 48.8 ± 0.1 51.7 ± 0.4 
15hTBA 0.75 ± 0.07 46.8 ± 0.1 n. d. 
29hTBA 64.17 ± 4.81 40.4 ± 0.2 40.9 ± 0.4 
 
Table 2.2: K
+
 apparent dissociation constant (Kd) and melting temperature (Tm) of tested 
aptamers determined by CD spectroscopy and fluorescence melting curves in buffer 
containing 50 mM KCl. 
n.d.: not determined 
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2.3.2 Binding of oligonucleotides to the human thrombin 
 
The DNA-thrombin complex formation was tested by following the reduction of nucleic 
acid electrophoretic mobility upon protein complexation. [88-90] 
The polyacrylamide concentration (12%) and consequentially the dimension of the pores in 
the gel was chosen to efficiently resolve the free and protein bound tested oligonucleotide. 
The protein concentration required to delay tested aptamers reflects the aptamer-thrombin 
binding affinity (Fig. 2.3). In our experimental condition the observed ranking order was the 
following: 29hTBA≤15fTBA<<15hTBA which indicates that the 15hTBA is a very poor 
thrombin binder.  This evidence suggests a relevant role of the steam portion of 29hTBA in 
the stabilization of the DNA-protein complex. 
Interestingly, 15hTBA presents an Adenosine in position 4: such mutation in 15fTBA has 
been reported to dramatically reduce aptamer-protein complex formation [91]. 
 
 
 
Fig. 2.3: DNA ( 1 µM) electrophoretic mobility shift induced by increasing protein 
concentration (0; 0.45; 1.35; 2.7; 8.1 and 10.8 μM). 
 
Obviously, no indication of overlapping binding site can be directly obtained by these 
EMSA results. However, we took advantage of the different electrophoretic mobility of 
29hTBA in comparison to 15-mers to perform a competition assay. Interestingly, the 
binding to the protein to the longer aptamer does not prevent binding of 15fTBA, whereas it 
partially suppresses complexation of the poorer binder 15hTBA (Fig. 2.4). The conclusion 
follows that 15fTBA binds exosite I (as expected), whereas 15hTBA shares with its larger 
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congener recognition of exosite II, although binding to different protein portions (likely 
exosite I) can occur. This means that by removing the stem portion the oligonucleotide 
preference changes thus suggesting that the binding site selection depends by G-quadruplex 
composition as well as by the presence of accessory binding domains. Therefore the two 
structural domains of 29hTBA have complementary roles in selective binding to exosite II, 
the stem region being more important for specificity. On the opposite, the change in the loop 
sequence from GCA to TGT confers selectivity for exosite I and dramatically reduces 
affinity for exosite II.  
 
 
 
Fig. 2.4: Relative amount of aptamers bound to thrombin when the reaction mixture 
contained an equimolar concentration of aptamer sequences. Reaction products were 
resolved by EMSA. 
a) 29hTBA / 15fTBA / 10 μM of thrombin;  
b) 29hTBA; c) 15fTBA; 
d) 29hTBA / 15hTBA / 10 μM of thrombin;  
e) 29hTBA; f) 15hTBA 
 
 
Due to the presence of several positively charged amino acid residues at exosite II level (and 
I as well), selective thrombin recognition by 29hTBA might be the result of effective 
charge-charge interaction favoured by the larger number of phosphate groups in comparison 
to the 15nt analogues, thus irrespectively from sequence or pairing effects. To asses which is 
the contribute of electrostatic binding to form adequately stable DNA-protein complexes, we 
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performed EMSA experiments with two families of linear synthetic oligonucleotides (Fig. 
2.5). The first family comprises polydeoxythymidine oligonucleotides of different length (n 
equal to 10, 20, 40 and 60 residues). Data analysis showed that up to 20-mer, no bands 
corresponding to the complex were observed (EMSA assays shown only for (dT)10 and 
(dT)60). Conversely, in the presence of longer DNA chains, relevant formation of the 
protein-DNA complex occurred. This clearly indicates that unfolded oligomers can also bind 
to thrombin with an efficiency modulated by the chain length and supports the hypothesis of 
an effective charge-charge interaction occurring between protein and DNA. Then, we 
compared in the same assay DNA sequences of the same length (40 residues) but having 
different sequences, selected to avoid intra- or inter-molecular folding ((dC)40, (dA)40, and 
(dGT)20). Interestingly, alternating GT sequences seems to demonstrate a higher affinity 
than all other tested sequences. (Fig. 2.5) Thus, although the protein-nucleic acid complex 
formation is noticeably promoted by charge-charge interactions, DNA base composition 
turned out to be also relevant in the nucleic acid-protein recognition process. 
 
 
 
Fig. 2.5: DNA ( 1 µM) electrophoretic mobility shift induced by increasing protein 
concentration (0; 0.13; 1.3; 2.6; 5.2; 7.8 and 10.4 μM)  
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2.3.3 Competition of single stranded oligonucleotides with thrombin 
aptamers binding. 
 
Due to the evidence of multiple contributions in the aptamer-protein binding process, it is 
useful to better define if DNA chain length and base composition might play a comparable 
role at exosite I and exosite II level. As experimental protocol we employed a fluorescence 
quenching assay [92-94] using the two aptamers 15fTBA and 29hTBA (known to be able to 
discriminate between the two protein binding sites), labelled at 5' end with FAM and 3' end 
with DABCYL. When DNA is unfolded, fluorescence is clearly detectable; upon G-
quadruplex formation the two labelling groups are in close proximity thus the fluorescence 
is quenched. This allowed us to monitor the DNA melting profile in different experimental 
conditions (Fig. 2.5). 
 
Fig. 2.5: Schematic representation of the fluorescence quenching assay. 
The temperature increasing induces the G quadruplex melting. 
In the unstructured DNA the fluorescent probe is positioned to an higher distance to the 
fluorescent acceptor tag. In this condition the specific fluorescence of the tag is clearly 
detectable. 
 
According to CD data, lower K
+
 concentrations were required to stabilize 15fTBA folding in 
comparison to 29hTBA (Fig. 2.7). Additionally, upon addition of Na
+
 up to physiologically 
relevant concentrations (150 mM), no clear melting transitions of labelled 15fTBA could be 
detected whereas a folded form of 29hTBA could be identified. 
Interestingly, thrombin was able to stabilize aptamers structure both in the presence and in 
the absence of the two tested monovalent ions (Fig. 2.7). This indicates that the chaperone 
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role of the protein is maintained towards both aptamers although a synergic effect is exerted 
by the metal ion. Indeed, the melting temperature observed at saturating protein 
concentrations (1 µM) results higher in the presence of K
+
, thus, confirming a major role 
played by the G-quadruplex form in mediating DNA-thrombin recognition is confirmed. 
 
 
 
Fig. 2.7: Thermal melting profiles of labelled 15fTBA (PANEL A) or 29hTBA (PANEL B) 
recorded in the presence/absence of different combinations of 50 mM KCl, 150 mM NaCl 
and 1 µM thrombin. 
The entity of the melting temperature of the thrombin-bound 15fTBA (red bars) and 
29hTBA (purple bars) in different experimental conditions is summarized in the PANEL C. 
 
The thermal shift promoted by thrombin was then used to asses if unlabelled DNA 
sequences can compete for binding to the site recognized by each aptamer. When a potential 
competitor is added in the reaction mixture, a reduction in the melting temperature of the 
protein bound aptamer is expected. Results obtained in 50 mM K
+
 (where the thrombin 
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mediated thermal shift of the aptamers is maximal) are summarized in Fig. 2.8. As expected, 
no competition occurred between the two aptamers. The core 15hTBA was able to promote 
a modest displacement from the protein of both labelled aptamers. This is totally consistent 
with the EMSA competition results described above and reinforces the hypothesis of its 
possible binding to exosite I as well II. 
None of tested single stranded DNA sequence previously used was able to displace thrombin 
from 15fTBA (Fig. 2.8). Different results were obtained in the presence of 29hTBA. 
Addition of (dT)n to the aptamer-protein complex promoted a remarkable reduction of the 
DNA melting temperature (Fig. 2.8). As previously described for EMSA experiments, this 
effect is a function of the length of the competitor DNA sequence. In particular the 20mer 
oligonucleotide is inactive, the 40mer one is modestly active whereas 60mer one is able to 
sensibly reduce the melting of the protein-bound 29hTBA. This behaviour could be related 
to competition for charge interaction. However, if we normalize the charge effect by 
calculating competitors concentrations in terms of phosphate residues, the same order is 
maintained suggesting that other contributions can at least cooperate in describing this trend. 
DNA sequence context plays also a role as shown by aptamer displacement measurements 
using oligonucleotides of equal length (same net charge) but different base composition. In 
fact, base composition modulates the extent of 29hTBA release from the protein bound form 
(Fig. 2.8). In particular, the most efficient competitors turned out to be (dAC)20 and, to a 
lesser extent, (dC)40.  
The different aptamer displacement efficiency showed by tested linear oligonucleotides 
toward the two tested aptamers suggest that the binding of the unfolded DNA occurs 
essentially at the exosite II level whereas for these sequences effective interaction with the 
fibrinogen recognition exosite is basically not apparent. Interestingly, the AC sequence 
selectivity, shown by competition experiments with linear oligonucleotides, appears to 
correlate with the composition of 29hTBA, where CA steps a substitute the TG steps 
peculiar of 15fTBA: this can envisage a correlation between the competition efficiency and 
the sequence of the longer G-quadruplex loop. 
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Fig. 2.8: Variation of the melting temperature of labelled TBAs (0.25 µM) in complex with 
thrombin (0.5 µM) upon increasing concentrations of test oligonucleotides recorded in the 
presence of 50 mM KCl.  
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2.3.4 Modulation of thrombin enzymatic activity by aptamers and 
unfolded DNA. 
 
It is reported that ligands binding to thrombin exosite I or exosite II can alter the proteolytic 
activity of the protein according to an allosteric crosstalk or an enthalpy-entropy 
compensation effect [95, 96]. To investigate a possible correlation between DNA binding 
and modulation of the enzymatic kinetics, we evaluated the effect of tested oligonucleotides 
on the rate of enzymatic cleavage of a chromogenic substrate by thrombin. In figure 2.9 the 
initial hydrolysis rate as a function of DNA concentration is reported. 
Increasing concentrations of 15fTBA did not inhibit thrombin enzymatic activity. This is not 
odd since the binding between 15fTBA and thrombin, occurring at the fibrinogen 
recognition exosite may not substantially alter the recognition and cleavage of a small 
synthetic substrate. On turn, both 29hTBA and 15hTBA modestly reduce substrate cleavage 
rate. Thus, different consequences at the level of the catalytic action upon aptamers binding 
at different protein exosites can be envisaged.  
Using linear (dT)n we observed a relevant impairment of the enzyme cleavage reaction that 
actually parallels the binding affinity order previously described: it increases with the DNA 
length up to levelling off at about 40 bases. By comparing different DNA sequences, it 
emerged a modest modulation, only (dA)40 being remarkably less efficient. Since (dA)40 was 
shown by EMSA to be a poor binder, the overall data suggest a correlation between enzyme 
binding affinity of the unfolded DNAs and their impairment of thrombin activity. 
Apparently, exosite II occupancy by a polyanionic macromolecule directly affects the 
enzymatic cleavage activity. In this connection, aptamers 15hTBA and 29hTBA appear as 
outliers. Nevertheless, the inhibitory action on thrombin, can be the result of several factors: 
for example an inhibitor effect mediated by the action of an allosteric site or a competition 
for the substrate recognition: it is conceivable that these processes can be differently 
modulated by folded and unfolded DNAs at least because, due to their G-quadruplex 
arrangement, aptamers are folded and thus cannot likely explore protein regions far from 
their binding exosite.  
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Fig. 2.9: Modification of thrombin (4.5 nM) cleavage rate (vo, s
-1
) of a chromogenic 
substrate (72 μM Benzoyl-Phe-Val-Arg-pNA) recorded in the presence of increasing DNA 
concentrations in phosphate buffer, pH 7.4.  
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2.4 Conclusions 
 
The molecular basis for recognition of distinct thrombin exosites by 15fTBA and 29hTBA is 
still not fully understood. A previous report suggested that they could adopt two different G-
quadruplex topologies. However, our data indicate that both assume a common antiparallel 
G-quadruplex folding thus ruling out the involvement of a different structural motif in the 
site selection process, (the parallel 29hTBA form is only transiently observed prior to 
annealing). Clearly the two aptamers have different loop sequences that are surely playing a 
role to produce a selective pattern of interactions, as confirmed by the fact that loop 
modification from 15fTBA to 15hTBA preserves an antiparallel G-quadruplex 
conformation, but allows aptamer shuffling between both exosites. Interestingly, addition of 
the two partially paired arms to obtain 29hTBA is crucial both to provide remarkably higher 
affinity for thrombin and for direct binding towards exosite II only. This demonstrates a 
combined role played by the stem and G-quadruplex portions of the longer aptamer. Indeed, 
correct pairing of the two arms induces the thermodynamically more favourable antiparallel 
G-quadruplex folding and generates an additional binding domain to produce effective and 
selective exosite recognition. 
To assess if this combination is synergic or not we used single stranded DNA model 
sequences characterized by different length and composition. Our results indicate 
predominant binding of these sequences at the exosite II of thrombin. This is not surprising 
since we can equalize these DNAs to linear arrays of negatively charged residues in analogy 
to heparin and GAGs, the physiological ligands of the above exosite. Additionally, the 
longer the sequence the stronger the binding is, thus further underlining a substantial 
contribution of charge-charge interactions. However, it is important to highlight that the 
efficiency of 29hTBA displacement is not simply correlated to thrombin affinity of the 
linear oligonucleotides, but it is finely tuned by its base sequence too. Interestingly, linear 
CA oligomers sharing the dinucleotide repeat with the longer loop of 29hTBA most 
efficiently compete for exosite II occupancy. This further reinforces the need to establish 
well defined nucleotide-protein interactions, deriving from a subtle interplay of sequence, 
length and structure, for effective exosite selection.  
44 
A final comment must be deserved to the consequences of DNA binding on the modulation 
of thrombin activity. In our conditions, we observed that only exosite II binders reduced the 
cleavage rate of a short substrate. Nevertheless 29hTBA, which binds to the same site with 
high affinity, is actually a poor inhibitor. A hypothesis to rationalize this behaviour rests in 
the smaller average dimension of the aptamer: although it is structurally organized in two 
main domains, tight folding cannot allow its arms to reach far from the G-quadruplex core. 
On the opposite, the single stranded DNAs that we tested are generally expected to assume 
an extended form: accordingly they can enforce their protein binding by forming 
interactions also with protein portions adjacent to the one strictly recognized by the aptamer. 
In this connection, several positively charged Lys/Arg residues are available on the protein 
surface to grant additional charged interactions with the interfering oligonucleotide. It is 
now to clarify if they act by inducing a protein conformational change or if they directly 
shield the access of the substrate to the cleavage site thereby affecting protein catalytic 
activity.  
In conclusion, our data confirm that the thrombin-aptamers interactions occurring at exosite 
I and II are remarkably distinct. Exosite I is effectively bound by 15fTBA in a folded 
quadruplex form: this arrangement contains the structural information needed to provide 
significant binding site selection (loop(s)) and good binding affinity (charge). On the 
opposite, a combination of two structural motifs (stem and G-quadruplex loop) is required to 
provide selective targeting for exosite II, additional binding strength being granted by a 
larger number of charged residues. Thus, the rational strategies to optimize 15fTBA and 
29hTBA in view of their potential therapeutic applications must be substantially 
differentiated. 
 
The data have been published in:  
G. Marson, M. Palumbo, S. Claudia; Folding versus charge: understanding selective target 
recognition by the thrombin aptamers. Current Pharmaceutical Design (Curr Pharm Des.) 
2012;18(14):2027-35.  
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3. Molecular versatility of the quadruplex/duplex structure in the 29-
mer Thrombin Binding Aptamer  
 
3.1 Introduction 
 
The impressive affinity and specificity associated with the aptamer-target complex 
formation derives from a mutual conformational adaptability. [44] Upon the target 
recognition, the aptamer binding domain as well as its target, according to their structural 
features, adjusts their surface to maximize complementarity through tightly packed contacts. 
When a lack of an unambiguous and detailed structure of protein-DNA complex is prevent, 
the nature of the binding interactions could be inspected only via an accurate set of 
complementary experiments. In the previous section we proposed that the higher target 
affinity of 29-mer thrombin binding aptamer (29hTBA) is probably gained from a peculiar 
co-presence of two structural modules, consisting of a 15-mer G-quadruplex core and of 
complementary 5’ and 3’ ends, potentially paired, to produce a quadruplex/duplex mixed 
structure connected by two 3-base bulges (see Fig. 3.1). This complex architecture appears 
to synergically promote a specific thrombin recognition. 
However, considering the complexity of the 29hTBAs’ topology some open questions 
emerge: which structural motifs are crucial for the thrombin recognition? Can the structural 
motifs identified in 29hTBA be treated as distinct modules? Are they interconnected in 
defining the thermodynamic stability and/or the thrombin affinity of the aptamer? To answer 
these questions, we designed and studied a series of 29hTBA analogous containing sequence 
modifications in single domains. In particular, to explore the functional role of the different 
loops inside the G quadruplex core we designed two mutants: the 29fTBA, consisting of the 
insertion of the 29hTBA 7 nt ends on the 15fTBA guanosine rich segment and the 
29hTBAm where we mutated the adenine in position 11 ( inside a minor loop) with a 
thymidine. This last modification was introduced in order to assay the role of the di-
nucleotides loops, basic structural domains for the thrombin recognition by the side of 
15fTBA, as evidenced in the crystallography model of the aptamer-protein complex (Fig. 
1.10).  
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To clarify the role of the double strand module inside the aptameric architecture we used 
29hTBAds (double strand) and 29hTBAnp (not paired). Their main differences with 
reference to the lead 29hTBA is given by the grade of complementary between the 
nucleotides forming the flanking ends. 
Conversely with the shorter sequence (22 nucleotides) 22hTBAss (single strand), 
characterized by the deletion of the 3’ eptanuclotide end, we investigated the behaviour of 
the guanosine rich core extended in 5’ position with a linear eptanucleotide appendage. 
As additional control we included the 23hTBAds which represents a further modification of 
the 29hTBAds, presenting only four pairing nucleotides at both 3’- 5’ ends. This shorter 
derivative was designed to explore the specific behaviour of a short double strand motif. 
Finally, we designed the 14hTBAhp (hairpin) which represents a 29hTBA analogous 
devoided of guanosine rich central chain, thus consisting only of the paired ends and the 
bulge loops connected. 
By studying this sequence, deprived of the guanosine repetition tract, we want to point out 
how the absence of a G4 module could influence the properties of the 14nt mutant. 
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Fig. 3.1: Schematic representations of oligonucleotides studied. 
 
To pursue this issue, the systematic characterization of the protein recognition profile of 
each designed sequence is focused to provide a deep insight into the role of each single 
portion. 
In this section, we applied the circular dichroism to characterize the conformational features 
of control oligonucleotides for which the ability to form either the duplex region or the G-
quadruplex region is particularly tuned 
Additionally, spectroscopic techniques and electrophoretic assays were used to study the 
binding properties of the novel DNA sequences. 
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3.2 Materials and Methods 
 
3.2.1 Materials 
 
Proteins. Human thrombin was supplied by Sigma Aldrich (St Louis, Missouri, USA) as 
lyophilized powder solubilized in water milliQ® at a final concentration of 27 μM (1 
mg/ml) and then stored at -80 °C.  
 
Synthetic oligonucleotides. HPLC purified oligonucleotides as well as  labeled form (3' 
FAM) were purchased from Eurogentec (Serain, Belgium) as lyophilized powder and 
solubilized in 10 mM Tris, 1 mM EDTA, pH 7.4. Oligonucleotide concentration was 
determined by UV absorbance at 260 nm. Before each experiment, DNA solutions were 
heated up to 95°C for 5 minutes and slowly cooled down at room temperature overnight in 
the required buffer. 
 
 
15fTBA 
29hTBA 
22hTBAss 
29hTBAds 
29hTBAnp 
23hTBAds 
29hTBAm 
29fTBA 
14hTBAhp 
 
5’- GGTTGGTGTGGTTGG -3’ 
5’- AGTCCGTGGTAGGGCAGGTTGGGGTGACT -3’ 
5’- AGTCCGTGGTAGGGCAGGTTGG -3’ 
5’- TGTGTGTGGTAGGGCAGGTTGGACACACA -3’ 
5’- AGTCCGTGGTAGGGCAGGTTGGGGTACTG -3’ 
5’- AGTCGGTAGGGCAGGTTGGGACT -3’ 
5’- AGTCCGTGGTTGGGCAGGTTGGGGTGACT -3’ 
5’- AGTCCGTGGTTGGTGTGGTTGGGGTGACT -3’ 
5’- AGTCCGTGGTGACT -3’ 
 
Table 3.1: Sequences reported for oligonucleotides studied. Nucleotides not included in the 
guanosine rich portion are evidenced in bold. 
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3.2.2 Methods 
 
Circular dichroism (CD). Circular dichroism spectra from 220 to 320 nm were recorded 
using 10 mm path length cells on a Jasco J 810 spectropolarimeter equipped with a Peltier 
temperature controller device to achieve constant temperature of 25 °C in a quartz cell with 
optical path length of 1 cm. The reported spectrum of each sample represents the average of 
3 scans recorded with 1-nm step resolution. Observed ellipticities were converted to mean 
residue ellipticity [θ] = deg x cm2 x dmol-1 (Mol. Ellip.).  
Apparent dissociation constants (Kd) for the G quadruplex stabilizing ions were calculated 
by fitting the relative variations of CD signal at 295 nm or 260 nm (K
+
 and Na
+
, 
respectively) as a function of the corresponding ion concentration. The relative variations of 
CD signal were obtained as Δθ/Δθmax and the data were elaborated using the data analysis 
module of Sigma Plot (Systat Software Inc.) accordingly to a single binding model. 
The melting curves were acquired recording the CD signal at 295 nm while applying a 
heating rate of 1°C/min. Tm values were obtained from the minima in the first derivatives of 
the melting profiles using the Jasco software. 
The buffers used for the CD experiments contained 10 mM Tris-HCl at pH 7.4 in addition to 
the indicated KCl/NaCl concentrations. Solutions were titrated with a concentrated KCl 
solution (3 M) or NaCl (2 M), by stepwise addition of 2–5 μl aliquots until no further 
changes in spectrum took place. 
The CD spectra of thrombin (in the absence or presence of aptamers) were measured with a 
J-810 Spectrophotometer at 212–320 nm using a two compartments 10-mm path-length cell 
at 10 mM Tris-HCl pH 7.4 buffer containing 50 mM KCl or 150 mM NaCl.  
The final concentration of thrombin was set at about 0.5 µM. The molar ratio of 
thrombin/aptamer was 1:1. 
 
Fluorescence binding study. Labeled aptamer-thrombin interaction was studied by 
recording the change of DNA probe’s fluorescence at λmax (i.e., 518 nm) as a function of 
thrombin concentration. The interactions were monitored at 25 °C by adding to solutions of 
3’FAM-15fTBA (48 nM) and 3’FAM-29hTBA (20 nM) in 10 mM Tris, 50 mM KCl pH 7.5 
a suitable stock solution of thrombin, up to reach a final protein/DNA molecular ratio of  
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and 20.5 for 15fTBA and 29hTBA, respectively. The fluorescence emission spectra from 
500 nm to 595 nm were recorded on fluorescence spectrofluoremeter Jasco model FP-, using 
a 10-mm path-length quartz cell. The excitation wavelength was set at 495 nm. 
Fluorescence intensity data were finally corrected for dilution (< 7.5% at the end of the 
titration) and finally expressed as [(F0-Fobs)/∆Fmax] where F0 and Fobs are the fluorescence of 
the DNA label in the absence and presence of thrombin, respectively, and ∆Fmax is the 
maximum fluorescence change at saturating concentration of protein. Binding constant (Kd) 
was calculated by fitting the λ518 fluorescence changes expressed as  [(F0-Fobs)/∆Fmax] as a 
function of the total thrombin concentration and using the data analysis module of Sigma 
Plot (Systat Software Inc.) with a single binding model. For the competition assay, labeled 
29hTBA (0.02 μM) fluorescence intensities were recorded after the addition of competitors 
oligonuclotides (0-6 μM) in the presence of a constant thrombin concentration (0.18 µM) in 
10 mM Tris, 50 mM KCl pH 7.5. The EC50 of the competition assay were calculated using 
the data analysis module of GraphPad Prism (GraphPad Softwere Inc.) 
 
Electrophoretic Mobility Shift Assay (EMSA). DNA (1 μM) was incubated with 
increasing protein concentrations (0-11 μM) for 30 min at room temperature in 10 mM Tris, 
20 mM KCl (or 100 mM NaCl/KCl),  pH 7.4. Then the reaction mixture was loaded onto a 
12% native polyacrylamide gel (acrylamide:bisacrylamide 19:1) in 1X TBE buffer (89 mM 
Tris, 89 mM boric acid and 2 mM Na2EDTA) added of 20 mM KCl (or 100 mM NaCl/KCl).  
Gels were stained with GelRed® or Sybr Green II® and visualized and quantified on a 
Geliance 600 (Perkin Elmer). 
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3.3 Results 
 
3.3.1 Influence of the 5’ 3’ flanked sequences on the 29hTBA folding 
 
Target recognition by 29hTBA is inherently associated to its conformational polymorphism, 
given by the coexistence of multiple structural modules. In the previous section we defined 
and optimized a systematic protocol for the complete analysis of conformational behaviour 
of 29hTBA by CD spectroscopy. Here, we adopted the same analytical approach to evaluate 
the folding properties of the new aptamer series. 
Initially, we assessed the conformational features of 29hTBAds and 29hTBAnp, the first 
characterized by fully complementary steam portion and the second defined by terminal 
stretches unable to hybridize. Both sequences exhibit two CD signatures clearly distinct 
from the reference aptamer both in presence or absence of G-quadruplex stabilizing K
+
 ions. 
In particular, under stabilizing-cation-deficient conditions 29hTBAds presents the typical 
CD spectrum of linear DNA ( a positive large band at ca 260–280 nm and a negative band at 
ca 245 nm) [79] reasonably deriving from the pairing of the 3’ and 5’ terminal residues. 
(Fig. 3.2.B) Addition of saturating potassium concentration induced changes in the CD 
spectra which are in line with the induction of a G-quadruplex antiparallel structure. Indeed, 
the characteristic positive peak centred around 295 nm clearly emerges (Fig. 3.2.B). 
Conversely, the CD spectrum of 29hTBAnp in absence of potassium exhibits a modest 
positive band near 260 nm associated to a negative one near 240 nm. (Fig. 3.2.C) This 
feature does not recall the chiroptical profile of an unfolded DNA but suggests the presence 
of a fraction of G-quadruplex parallel form. Addition of K
+
 on this mutant sequence 
promotes a change in the CD pattern, leading to a new positive CD band at 293 nm 
associated with a 265 nm positive shoulder (Fig. 3.2.C). According to this CD signature, an 
univocal prediction of the G-quadruplex folding is not easy. 
Indeed, this CD patter could suggest either the presence of a mixed population of both 
parallel and antiparallel oriented strands distinct forms or the coexistence, inside the same 
structure, of the both stranded polarities in a mixed type form. 
Nevertheless, this result indicates that the absence of a correct pairing of the terminals 
prevents the folding of the G-rich strand towards an univocal antiparallel conformation.  
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To better understand the role of protruding terminals in the G4 folding process we studied 
23hTBAss which contains only the 5’ terminal eptanucleotide end. Its CD spectra, upon 
addition of potassium, displayed a negative Cotton band with a minimum around 265 nm 
and positive band at 295 nm (Fig. 3.2.D), a pattern consistent with the one reported for the 
29hTBA reference sequence (Fig. 3.2.A). This allows us to confirm that the loss of the 3’ 
flanked sequence in 29hTBA does not perturb the final G4 structure adopted. 
Thus, one impaired terminal is not sufficient to alter the functional folding of 29hTBA. 
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Fig 3.2. In PANELS A, B, C, D; Variation of CD spectra upon addition of KCl for 29hTBA 
(purple line), 29hTBAds (bondi blue line), 22hTBAss (dark blue line) and 29hTBAnp 
(yellow line). CD spectra in the absence (dashed line) or presence (solid line) of saturating 
concentrations of K
+
 ions are evidenced. DNA concentration 5 µM in 10 mM Tris, pH 7.4. 
The arrows indicate the variation induced by the increasing K
+
 concentrations. 
In PANEL E; CD spectra of aptamers in the absence of K
+
 ions are reported. 
In PANEL F; CD spectra of aptamers at saturating concentrations of K
+
 ions are reported. 
In the figure are reported schematic representations of oligonucleotides studied in this 
section and a legend reporting the colour code of each DNA sequence. 
 
 
In order to estimate the apparent dissociation constant of the stabilizing potassium ions to 
aptamers, the quantitative analysis of the titrations was performed. The spectral data were 
analyzed, considering the relative variation of the 295 nm signal (the typical feature of an 
antiparallel CD spectrum) as a function of potassium concentration. The resulting plots are 
reported in figure 3.3.A. Since all CD titrations showed two isodichroic points for the tested 
oligonucleotides (257 and 278 nm), indicating the two-state nature of structural transition, 
we analyzed isothermal titrations according to one binding event. Among all the tested 
sequences, 23hTBAss showed the higher Kd for potassium (table 3.2). This result suggests 
that the presence of a single flanked chain favors the coordination of the alkali metal ion to 
the guanosine tracts. Furthermore, the 3-fold difference for the Kd between 29hTBAds and 
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29hTBAnp sequences, which differ for the pairing of the terminal portions, indicates that the 
duplex strand region cooperates in potassium driven folding for the studied G rich chains 
likely forcing the 3’ and 5’ terminal of the G-rich portion to be correctly located to form the 
antiparallel G-quadruplex. To further elucidate the contribution of the flanking sequences to 
G-quadruplex stability, we investigated the melting profiles of 29hTBA mutants in buffer 
containing 50 mM KCl. The plot of the dichroic signal at 295 nm as a function of 
temperature for the studied mutants is presented in figure 3.3.B. These curves evidenced 
how the increment of the temperature promotes the unfolding of the ordered DNA 
structures, which is displayed by a CD magnitudes decrease. Under comparable conditions 
G-quadruplexes formed by 29hTBAnp and 23hTBAss turned out to be more stable than the 
references aptamer, presenting melting temperatures of 49.8 °C and 48.6 °C, respectively 
(Fig. 3.3.B and Table 3.2). 
If this result is somehow expected for 29hTBAss and is in line with its higher propensity to 
arrange into an antiparallel G4 in the presence of K
+
, it appears odd for 29hTBAnp which 
showed a low affinity for this metal ion. However, it is worth to recall studied the 
ambiguous folding adopted by 29hTBAnp in potassium condition. 
If the melting temperature of the antiparallel G4 is initially monitored the change of the 
signal at 295 nm, the thermal-induced changes recorded at 260 nm should describe the 
unfolding of the parallel G4. 
Thus, to further understand the 29hTBAnp behavior we estimated and compared the two 
different melting profiles, obtained by recording the thermal-induced reduction of the CD 
signals at 260 and 295 nm (Fig. 3.3.C). Even though we could not calculate exactly the 
minima in the first derivatives of the melting profiles for the 260 nm signal, results clear that 
the specific form that contributes to the 260 nm signal is more thermally stable then the 
antiparallel form. This implies that the two strand orientations do not coexist inside the same 
structure but belong to distinct structures simultaneously present in solution, defined by 
distinct thermodynamic stabilities. 
Finally, by increasing the antiparallel component the thermal stability largely increments. 
The thermal stability of 29hTBAds was estimated to be around 40.0 °C thus similar to the 
one of 29mer references sequence. These results assign a controversial role to the duplex 
module: on the one hand it promotes G4 folding upon addiction of potassium with reference 
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to 29hTBA, on the other it is not sufficient to produce a G4 as thermally stable as 
29hTBAss. To sum, these results point on how thermodynamic stability of an antiparallel 
folding could be tuned by inserting specific Watson-Crick pairing elements. 
 
 
 
 
Fig 3.3. In PANEL A; relative variations of the CD intensities recorded at 295 nm are 
reported as a function of KCl concentration. 
In PANEL B; melting profiles of selected aptamers recorded monitoring the CD signal at 
295 nm in 50 mM K
+
. 
In PANEL C; melting profiles of 29hTBAnp recorded monitoring the CD signal at 295 nm 
(solid line) and 260 nm (dashed line) at 50 mM K
+
. 
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 Kd (mM) Tm (°C) 
29hTBA 64.17 ± 4.81 40.4 ± 0.2 
29hTBAds 17.00 ± 2.46 40.0  0.2 
29hTBAnp 53.65 ± 9.60 49.8  0.2 
22hTBAss 8.24 ± 7.70 48.6  0.2 
 
Table 3.2: K
+
 apparent dissociation constant (Kd) and melting temperatures (Tm) of tested 
aptamers determined by CD spectroscopy in buffer containing 50 mM KCl. 
 
 
3.3.2 Influence of the guanosine rich core on the aptamer folding  
 
Literature data indicate that loops composition can largely affect the conformational 
equilibria of G-rich sequences in terms of folding kinetics and stability [13-15, 92, 97-103]; 
in particular a stabilizing effect of thymine residues has been underlined by crystallography 
studies. [16] 
To assess if minimal nucleobase modifications actually affect the overall G-quadruplex 
structural properties of 29hTBA we performed a comparative biophysical analysis of the 
following G-rich DNA sequences. 
The first sequence (29hTBAm) consists of the 29hTBA sequence with an A-T mutation at 
position 11. 
Conversely, the 29fTBA is defined by 15fTBA G-rich sequence merged into the peculiar 
molecular architecture of the 29hTBA. For this mutant sequence A11 is substituted by T11 
and TGT replaces GCA in the major loop. Interestingly, loop composition does not 
influence the folding process in terms of overall structure since the comparison of the CD 
spectra for the three sequences suggested a common antiparallel structure adopted upon 
addition of potassium ions (Fig. 3.4). 
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Fig. 3.4: In PANELS A, B, C; Variation of CD spectra upon addition of KCl for 29hTBA 
(purple line), 29hTBAm (light green line) and 29fTBA (orange line). CD spectrum in the 
absence (dashed line) or presence (solid line) of saturating concentrations of K
+
. DNA 
concentration 5 µM in 10 mM Tris, pH 7.4. 
The arrows indicate the variation induced by the increasing K
+
 concentrations. 
In the figure are reported schematic representations of oligonucleotides studied in this 
section and a legend reporting the colour code of each DNA sequence. 
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Interestingly, the monovalent metal ion concentrations required to fully convert the three test 
sequences into the G-quadruplex form are different (Fig. 3.5.A and table 3.3). In particular 
this is extremely reduced (about six folds) for the mutant 29hTBAm. For this last sequence 
the Kd is 10.8 mM, where the corresponding value for reference 29hTBA is 64.8 mM. 
For the 29fTBA sequence the apparent dissociation constant for K
+
 is approximately three 
folds lower in comparison to the reference 29hTBA (Table 3.3) This last finding is perfectly 
consistent with our previous study in which we reported that the dissociation constant for 
15fTBA (the first binding aptamer identified and the G quadruplex core of the 29fTBA) is 
approx. 3 fold lower in comparison with 15hTBA (the G quadruplex core of the 29hTBA) 
(see table 3.3) [104]. The results above-described clearly indicate how loops composition 
can specifically influence the guanosine coordination of K
+
. 
The analysis of the thermal stability evidenced how the three 29nt DNA sequences present 
lower melting temperatures in comparison to the corresponding 15nt guanosine rich cores 
(15fTBA and 15hTBA) of approximately 8 °C. 
These results clearly point out how loop composition negligibly influences the thermal 
stability of the G4 core. 
 
 
Fig. 3.5: In PANEL A; relative variations of the CD intensities recorded at 295 nm are 
reported as a function of KCl concentration. 
In PANEL B; melting profiles of selected aptamers recorded monitoring the CD signal at 
295 nm in 50 mM K
+
. 
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 Kd (mM) Tm (°C) 
15hTBA 0.75 ± 0.07 46.8 ± 0.1 
15fTBA 0.41 ± 0.17 48.8 ± 0.1 
29hTBA 64.17 ± 4.81 40.4 ± 0.2 
29fTBA 18.81 ± 8.60 36.5 ± 0.1 
29hTBAm 10.80 ± 1.52 39.2 ± 0.2 
 
Table 3.3: Monovalent ions apparent dissociation constant (Kd) and melting temperatures 
(Tm) of tested aptamers determined by CD spectroscopy in buffer containing 50 mM KCl. 
 
 
 
 
3.3.3 Binding analysis on 29hTBA and mutants to the human thrombin 
 
The mutant oligonucleotides showed large variability in terms of folding and variability, we 
can assume such a structural plasticity can largely affect their recognition properties of the 
target protein. Thus, we performed a comparative analysis of thrombin binding efficiency by 
means of Electrophoretic Mobility Shift Assay (EMSA), a straightforward method to study 
Gq DNA-protein binding. [88] A summary of the results is reported in figure 3.6. We can 
assume that, in suitable conditions, the protein concentration required to retard DNA chains 
is directly related to the DNA-protein binding affinity and stability. This approach allowed 
us to identify the following binding affinity ranking order 
29fTBA>29hTBAds≥29hTBAnp>29hTBA=29hTBAm>>23hTBAss. (Fig. 3.6) 
These findings highlight how our modifications can largely affect the recognition of the 
physiological target. In particular the loss of the 5’ flanked chain brings to a dramatically 
reduction in aptamer-protein complex formation. This evidence perfectly agrees with our 
past results that highlighted how the binding presents an outstanding electrostatic component 
given by the charge-charge interactions between DNA phosphate backbone and the 
numerous basic amino acids localized on thrombin surface. This model is further reinforced 
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by the complete loss of affinity for the 23hTBAds, a 29hTBAds analogue presenting shorter 
flanking sequences (3nt instead 7nt). This last electrophoretic analysis evidenced that a 
minimal sequence difference of 4 nucleotides at the 3’ and 5’ ends is the structural cut off 
between an active binder and an inactive one. 
It is worth to underline that a perfect pairing of the 7nt residues of the 3’ and 5’ terminals 
(29hTBAds), seems to increase the affinity in comparison to the reference DNA sequence, 
proving that the duplex domain actively participates in specific interactions with the 
thrombin. 
Surprisingly, the presence of not paired terminal modules (29hTBAnp) did not reduce the 
protein affinity as we could expect.  
Our expectation was actually based on the structural differences that this sequence showed 
in K
+
 containing solutions. However, we should keep in mind that the protein can work as a 
chaperon likely forcing even 29hTBAnp toward a thrombin-suitable conformation. 
To evaluate in which manner loop composition modulates 29mer aptamer-protein 
recognition, we investigated the behaviour of 29hTBAm and 29fTBA in the presence of an 
increasing amount of thrombin. Our results indicate that the protein concentrations required 
to completely retard the 29hTBAm is fully comparable with the one of the 29hTBA protein 
binding profile, so a minimal mutation in the minor loop seems not able to alter the 
recognition ability of 29hTBAm. 
Distinctly, the analogous 29fTBA showed the higher affinity in the mutant series. 
Additionally, it showed an unique behaviour. Indeed, by analysing the electrophoretic 
mobility shift induced by increasing protein concentrations we can distinguish two different 
retarded DNA form, 
Clearly, this suggests the formation of protein-DNA complexes with different stoichiometry. 
By comparing the electrophoretic mobility of these species with those obtained with 
comparable length we can propose that the first complex represents a 2:1 DNA-thrombin 
complex whereas the second one, occurring at higher thrombin concentration, corresponds 
to a single DNA chain bound to one thrombin. 
Regarding the structural modules involved in binding, further questions deserve to receive 
our attentions: which is the specific role of the guanosine tetrads in the binding event? Do 
they directly interact with the target according to their peculiar folding or are only required 
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to properly force the loops in specific arrangement required for the binding? Without a 
strong set of structural data that could define properly the interactions occurring at the G-
quadruplex-protein interface, we try to answer the question by studying an additional 
guanosine rich sequence. 
The 14hTBAhp is composed only by the two 29hTBA’s eptanucleotides ends covalently 
linked, without the G-rich core that characterizes the reference aptamer. For this shorter 
sequence, EMSA assay showed that the ability to recognize the target is totally lost. This 
finding could suggest that both an individual bulge loop motif (14hTBAhp) and minimal 
modifications of loop nucleotides between two antiparallel G quadruplex form (29hTBA and 
29fTBA) could strikingly modulate the binding tendency. Hence, we can propose G-tetrads 
as important structural elements involved in the binding but we also need to consider the 
additional modular elements of the aptamer, such as the loops nature and length and the 
specific flanked sequences. 
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Fig. 3.6: DNA (1 µM) electrophoretic mobility shift induced by increasing protein 
concentration. 0; 0.45; 1.35; 2.7; 8.1 and 10.8 μM for 29hTBA and 29hTBAm. 
0; 0.45; 1.3; 2.6; 5.7; 8.1 and 10.4 μM for 22hTBAss, 29hTBAds, 29hTBAnp and 29fTBA.  
0; 0.45; 1.3; 5.7 and 10.8 μM for 23hTBAds and 14hTBAhp. 
All the assays were conducted in KCl solution (20 mM).  
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3.3.4 Mapping the thrombin binding sites, a multiple characterization 
 
To go into the details of binding properties of 29fTBA and 29hTBAnp mutants, we carried 
out a series of electrophoretic competition assays. In this case we took advantage of the 
availability of two the fluorescein labelled TBAs (15fTBA and 29hTBA). They were 
opportunely mixed with the unlabelled competitor DNA mutants and thrombin (Fig. 3.7 and 
3.8). 
For this experimental assay when a potential competitor is added to the protein-aptamer 
mixture, a restoration of the unbound aptamer (defined by a major electrophoretic mobility), 
could be expected if the added sequence is defined by an higher affinity for the same 
binding site. 
According to the different exosite selectivity of 15fTBA and 29hTBA this approach allows 
us to map at which site the competition eventually occurs. 
The selectivity of the 29hTBAnp for the heparin binding domain is fully confirmed by the 
gel competition assay. Indeed the addition of this oligonucleotide fully suppresses 
complexion only of the 29-mer binder labelled (Fig. 3.7 lane C’). This result could be 
explained only assuming a clear preference of the 29hTBAnp for the exosite II. 
Conversely, when we stain the EMSA gel with a nucleic acid binding dye, in the lanes 
containing the combination 15fTBA fluo/29fTBA (Fig. 3.8 lane C) and 29hTBA 
fluo/29fTBA in the presence of thrombin (Fig. 3.8 lane) we were not able to detect a clear 
band referring to single strand DNA in the free form. This finding could indicate that in both 
cases the two DNA sequences co-incubated are simultaneously bound to the thrombin. 
Thus, we can presume that 29fTBA hampers the protein target even if is partially buried by 
one of the two fluorescent aptamers. 
To sum up, the binding behavior of the 29fTBA opens new scenarios for the conventional 
thrombin recognition patterns, suggesting new possible thrombin interaction modes for this 
hybrid thrombin binding aptamer. 
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Fig. 3.7: 29fTBA and 29hTBAnp mutant-protein selectivity for exosite II studied by EMSA 
competition assay. To gain deeper information on the recognized exosites, different 
combinations of TBAs (6-carboxyfluorescein labelled 29hTBA / not labelled TBAs) were 
mixed with 10 µM of thrombin. 
The fluorescein labelled DNAs were visualized by fluorescence then all the ensemble of 
DNAs were stained with a nucleic acid binding dye. 
 
A) 29hTBAnp/ 10 μM of thrombin; B) 29hTBAnp; C) 29hTBA fluo/ 10 μM of thrombin/ 
29hTBAnp; D) 29hTBA fluo/ 10 μM of thrombin; E) 29hTBA fluo; F) 29hTBA fluo/ 10 
μM of thrombin/ 29fTBA; G) 29fTBA; H) 29fTBA/10 μM of thrombin 
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Fig 3.8: 29fTBA and 29hTBAnp mutant-protein selectivity for exosite I studied by EMSA 
competition assay. To gain deeper information on the recognized exosites, different 
combinations of TBAs (6-carboxyfluorescein labelled 15fTBA / not labelled TBAs) were 
mixed with 10 µM of thrombin. 
The fluorescein labelled DNAs were visualized by fluorescence then all the ensemble of 
DNAs were stained with a nucleic acid binding dye. 
 
A) 15fTBA fluo; B) 15fTBA fluo / 10 μM of thrombin; C) 15fTBA fluo/ 10 μM of 
thrombin/ 29fTBA; D) 29fTBA; E) 29fTBA/10 μM of thrombin F) 15fTBA fluo/ 10 μM of 
thrombin/ 29hTBAnp; G) 29hTBAnp/ 10 μM of thrombin; H) 29hTBAnp. 
 
 
To better characterize the different thrombin binding behavior showed by these DNA 
sequences we performed also fluorescence titrations.  
Direct DNA-protein titrations are difficult due to the overlapping absorbion/emission 
bands.of the two macromolecules Thus, we applied an experimental protocol based on the 
changes in fluorescence intensity of the above described fluorophore-labelled aptamers upon 
binding to thrombin. Because fluorescence is dependent on the molecular environment 
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around the fluorophore, close contacts between a labeled molecule and an interacting specie 
are expected to result in measurable changes of fluorescence intensity. 
With reference to the electrophoretic approach used in the EMSA assays (appropriate for a 
first screening) this technique allows to rigorously monitor the protein free and bound DNA 
at equilibrium conditions. 
As aptameric sequences we used 3’-FAM labeled 15fTBA and 29hTBA and we monitored 
changes of FAM florescence (λex 495 nm, λem 518 nm) upon the addition of the target 
protein. The protein caused a reduction of the maximum fluorescence emission of the probe 
showed for both labelled aptamers (around 16% and 23.4% for 15fTBA and 29hTBA, 
respectively) thus indicating a change in the molecular environment around the 3’ bound 
label due by the effective complex formation (Fig. 3.9). 
For the first reported aptamer, 15fTBA, the dissociation constant (Kd) calculated according 
to one binding site model was 184 nM. Distinctly, the 29 nt binder, 29hTBA, presents a 
stronger affinity with a Kd of approximately of 20 nM. The ratio between the two 
dissociation constants is consistent with those resulting from original literature data. [74] 
In particular, in the pioneer work of Tasset et al [74] a Kd of 0.5 nM, and 20 nM were 
reported for 29hTBA and 15fTBA, respectively. These values were obtained by a 
nitrocellulosa filter binding analysis. This last finding suggest a general consideration: how 
the technique employed and the sensibility of the analytical methods can influence 
remarkably the value that defines the same recognition event. 
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Fig. 3.9:  Aptamer-protein interaction studied by EMSA and fluorescence 
(A, D) DNA (1 µM) electrophoretic mobility shift induced by increasing thrombin 
concentration (0; 0.45; 1.35; 2.7; 8.1 and 10.8 μM for 15fTBA and 0; 0.45; 1.35; 2.7; 8.1 
and 10.8 μM for 29hTBA). 
(B, E) Florescence spectra of the 6 carboxyfluorescein probe that labels the DNA ( λex 495 
nm, λem 518 nm) without thrombin and at saturating concentration of thrombin. 
After addition of the thrombin the maximum fluorescence emission was impaired to 16% 
and 23.4% for 15fTBA and 29hTBA, respectively. 
(C, F) Changes of fluorescence intensity of 6 carboxyfluorescein probe that labels the DNA 
upon the increasing concentration of the protein. The final concentration of aptamer was 48 
nM and 20 nM for 15fTBA and 29hTBA, respectively. 
For simplicity, fluorescence data were normalized as [(F0-Fobs)/∆Fmax]. (Materials and 
methods). 
 
 
To assess which is the selectivity of the mutant G-rich sequences to the interacting portions 
of the thrombin, we performed a series of competition assays using both fluorescent labeled 
and unmodified aptamers. Starting from a solution of thrombin-bound labeled DNA, if the 
unlabeled sequence binds to the same binding site, then the fluorescently labeled aptamer, is 
expected to be displaced from the thrombin complex. As a consequence the restoration of 
the fluorescence intensity of the fluorophore, typical of the unbound state, is recorded.  
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This study was performed using the high affinity 29hTBA aptamer. By comparing the 
experimental results, we observed that the 29hTBAds and 29hTBAnp were able to 
completely displace the labeled aptamer with a similar profile (Fig. 3.10 and table 3.4). 
Otherwise, the 29fTBA, already characterized by unique folding properties and binding 
behavior, seems to be not able to displace 29hTBA from the exosite II (Fig. 3.10 and table 
3.4). 
This surprising outcome could indicate how a minimal change in the loop sequence, from 
GCA to the TGT of the 29fTBA, drives the selectivity on an accessory binding domain 
distinct from the exosite II. 
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Fig. 3.10: Aptamer-protein selectivity studied by fluorescence spectroscopy 
Relative variation of the fluorescence intensity of labeled 29hTBA (0.02 µM) bound to with 
thrombin (0.18 µM) upon increasing concentrations of nucleic acid competitors. 
The fluorescence data, for the competition assay, were expressed as the following [(Fmax-
Fobs)/∆Fmax]. 
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 EC50 (µM) 
29hTBAds 0.51 ± 0.01 
29fTBA n.d. (*) 
29hTBAnp 0.19 ± 0.04 
 
Table 3.4: EC50 of tested aptamers for the 5’-fluorescein 29hTBA bound to the target, 
determined by fluorescence spectroscopy in buffer containing 50 mM KCl. 
n. d. not determined 
(*) The displacement entity was not calculated due to a negligible change of the 
fluorescence intensity of FAM bound to the aptamer during the titration with the competitor. 
 
 
3.3.5 Modulation of aptamer properties by sodium monovalent ion. 
 
The previous sections underlined how 29fTBA showed a peculiar thrombin binding profile 
irrespectively to a folding behaviour comparable to 29hTBA in K
+
 containing solutions. 
Nevertheless K
+
 is not the only physiologically relevant G4 stabilizing ion. In particular, 
owing to its physiological importance, the other best studied monovalent ions is Na
+
. 
Structural studies indicated that potassium and sodium ions are placed between or within the 
cavities formed by stacked planar arrays, respectively. [21, 22] 
Due to this different binding mode the polymorphism exhibited by G-quadruplexes is 
largely influenced by selective interactions of the G-tetrads with different cations. [8, 18] 
Thus, we decided to investigate if the remarkable aptamer features observed in the presence 
of K
+
 are somehow conserved also in the presence of Na
+
. As target sequences we selected 
29hTBA and 29fTBA. Addition of sodium to 29hTBA did not change remarkably the 
undefined CD pattern, recorded under deficient metal ion concentration and which is 
reasonably given by a high fraction of disordered DNA molecules (Fig. 3.11). In particular, 
sodium promotes only a modest increment of the positive peak at 292 nm that suggests a 
minimal chiroptical contribution given by a low fraction of molecules adopting the 
antiparallel form (Fig. 3.11). More interesting results derived from the analysis of the Na
+
 
driven 29fTBA folding. In this case the metal ion promotes a remarkable increment of the 
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positive peak around 260 nm, which can be referred to a specific G4 parallel form (Fig. 
3.11). 
The plasticity emerged for 29fTBA in Na
+
 solution was also evaluated by the assessment of 
the apparent dissociation constant, derived from considering the relative variation of the 260 
nm CD signal (the signal that predominantly changes). For this sequence the Kd for Na
+
 is 
42.6 mM, approximately two fold lower in comparison to the corresponding constant for the 
potassium ion.  
 
 
 
Fig. 3.11: In PANEL A and B, variation of CD spectra upon addition of NaCl for 29fTBA 
(orange line) and 29hTBA (purple line). CD spectrum in the absence (dashed line) or 
presence (solid line) of 100 mM [NaCl]. DNA concentration 5 µM in 10 mM Tris, pH 7.4. 
In PANEL C; CD spectra of aptamers at 100 mM concentrations of Na
+
 ions are reported. 
 
 
This result, certainly, classifies 29fTBA as a surprising plastic structure. Indeed, we can 
easily control its conformational features upon changing environmental conditions. Thereby, 
we showed that minimum modifications within intra quadruplex loops can influence the 
ability of the guanosine strands to recognize and accommodate different stabilizing ions in 
peculiar molecular architectures. 
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As previously described, 29fTBA sequence exhibits a peculiar Na
+
-driven folding, thus we 
decided to investigate the binding affinity of the sequence in the presence of this metal ions. 
Noticeably, the presence of a sodium-driven parallel form does not influence the recognition 
process in terms of EMSA binding profile as reported in figure 3.12. 
In addition, we can observe that the higher ionic strength of the medium (100 mM NaCl) 
does not impair the inter-molecules binding, suggesting that the folded form adopted in 
sodium solution recognizes the target specifically with a molecular event that requires a 
minimal contribution of the electrostatic forces. 
Otherwise, for the same 29fTBA sequence, an increment of K
+
 potassium concentration  
from 20 mM to 100 mM disturbs significantly the binding of the target, avoiding a complete 
complexion of the protein as reported in the figure 3.13. 
Conversely, for 29hTBA sequence, high ionic conditions (100 mM KCl/NaCl) reduces the 
thrombin binding ability of the aptamer, irrespectively of the metal ions (Fig. 3.13). 
 
 
 
Fig. 3.12: . DNA (1 µM) electrophoretic mobility shift induced by increasing protein 
concentration (0; 0.45; 1.3; 2.6; 5.7; 8.1 and 10.4 μM) for 29hTBA and 29fTBA in 100 mM 
Na
+
 concentration (dashed lines).  
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Fig. 3.13: Percentage of aptamers bound to thrombin occurring at increasing concentration 
of thrombin at different ionic strength/buffer conditions (10 mM KCl, 100 mM KCl and 100 
mM NaCl). The binding assay was conducted via EMSA. 
 
 
In the previous experiments we largely described the binding events in terms of affinity and 
specificity, in this last part we wanted to answer to the following open question: the 
complexion with the thrombin could promote a conformational change in the DNA 
template? 
The chaperon-like activity of the thrombin is connected to its ability to promote the folding 
of the 15 monomers aptamer in cation-deficient-conditions. This property has been 
described in details both in the previous chapter and in the literature. [71, 104] 
Due to the peculiar results herein reported for some longer sequences we focused on the 
aptamer 29hTBA and the 29fTBA mutant in sodium and potassium conditions in order to 
fulfill the issue in an complete manner. 
To investigate the DNA folding rearrangement induced by the protein we adopted the 
differential circular dichroism. 
This approach allows us to monitor the overlapped chiroptical contributes of DNA and the 
protein, firstly separated in the two compartments of the cuvette and then mixed. 
Hence, the differential CD spectrum can be helpful in describing the structural 
rearrangements of the two macromolecules that undergo upon binding. (Fig. 3.14) 
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As an example, the subtraction of the differential spectra of both 29hTBA and 29fTBA in K
+
 
clearly showed absence of DNA arrangement (no signal is detected in DNA absorption 
region) (Fig. 3.15 PANELS A and C). This support that the folding of these aptamers 
promoted by the monovalent ion is essentially preserved in the presence of the protein. 
Conversely, we could detect a rearrangement upon thrombin binding undergone for the 
29fTBA in sodium condition (Fig. 3.15 PANEL D). By overlaying the DNA chiroptical 
contribute in presence and in absence of the thrombin we can identify a shift of the positive 
maximum from 260 to a new 295 nm signal. This finding indicates a conversion of the Na-
promoted parallel form to a newly thrombin-driven antiparallel form. The conclusion 
follows that specific chaperon activity of the thrombin, in sodium condition, is conserved 
also for the 29fTBA sequence. 
Considering the previous spectroscopic analysis we can propose the antiparallel G4 as the 
specific thrombin binding structure. 
The conformational behaviour of the 29hTBA in sodium condition results less clear. 
We can observe a minimal increase of the positive peak at 260 nm followed by a decrease of 
the 290 nm signal, both induced upon thrombin addition. This CD pattern change could be 
given by a minimal contribute of DNA (we should take in mind that in sodium condition the 
29hTBA is mainly unfolded) and a contribute given by the intrinsic CD spectrum of the 
protein, evidenced as the decrease of the signal in the far UV region (around 212 nm) and a 
reduction in the near UV region (around 285 nm). Both CD changes could be due to 
structural arrangement in the protein secondary structure and in the environment of the 
tryptophan residues. 
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Fig. 3.14: Example of a differential circular dichroism analysis. Overlapping of the CD 
spectra referring to free protein (black line), the free protein and free DNA separated (gray 
line) and the protein-DNA mixed (light gray line). 
 
Fig. 3.15: In PANEL A, B, C and D, the far-UV CD spectra of thrombin mixed with an 
equivalent concentration of 29hTBA (PANEL A and B) or 29fTBA (PANEL C and D) 
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subtracted of the corresponding CD spectra registered with thrombin/aptamers separated in 
the two compartments of the cuvette, recorded in the presence of 50 mM KCl (PANELS A 
and C) and 150 mM NaCl (PANELS B and D). Final DNA concentration 0.5 µM in 10 mM 
Tris, pH 7.4. 
The protein DNA molar ratio adopted for this assay was 1:1. 
 
 
 
 
Fig. 3.16: Differential CD spectra of 29fTBA mixed/unmixed with thrombin. 
In PANEL A and B; the CD spectra with DNA contribute not mixed (gray line) or mixed 
(black line) with an equimolar concentration of thrombin. 
Differential CD spectra are reported for 29fTBA in 50 mM KCl (PANEL A) or 150 mM 
NaCl (PANELS B) respectively.  
Final DNA concentration 0.5 µM in 10 mM Tris, pH 7.4. 
The protein DNA molar ratio adopted for this assay was 1:1. 
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3.4 Conclusions 
 
The high thrombin affinity reported for 29hTBA has been previously described as the results 
of the combination of two binding domain: one included in the G4 core and one provided by 
the double helix domain. 
However, a detailed observation underlined more structural moieties which can be critical to 
provide the best interaction of the two macromolecule. This is the case, for example, of the 2 
couple of 3 residues which connect the above mentioned domains as well as the G4 loops. 
The characterization of the role of these different structural motifs in defining the functional 
architecture of the nucleic acid is a promising goal in the to improve the effectiveness of this 
active biomolecule. In this work we exploited this aim by designing a series of 
oligonucleotides resulting from rational modifications of single structural motifs of 
29hTBA. Conformational studies highlighted that the pairing extension of the flanked arms 
could influence the conformational equilibria, in a surprising wide scenario of folding 
adopted: they can promote double strand forms (flanked sequence completely paired) or 
alternatively G-quadruplex parallel folding (terminal arms not paired). This multiple 
behaviour confirms and highlights the role of the stem loops in driving G tetrads 
arrangement. 
A detailed analysis of protein recognition of quadruplex – duplex coexisting forms, a 
constitutive feature of the 29nt aptamer, represents an issue that can be extended to a 
physiological context where the guanosine stretches of chromosomal DNA equilibrate 
between an Hoogsteen bonded quadruplex and a Watson–Crick hydrogen bonded duplex, 
formed with the C-rich complementary strand. A further comment must be deserved to the 
role of intra G-quadruplex loop composition, a crucial element in aptamer target affinity. 
The nature of the loops seems not influence the folding adopted, but has a role in defining 
the strength and specificity of metal ion accommodation within the folded structures. In 
particular, the mutant 29fTBA sequence, a 29hTBA and 15fTBA hybrid, can adopt multiple 
folding, depending on the nature of the monovalent metal cations. To sum up, the ensemble 
of the structural appendages that dress the minimal G quadruplex core cooperates in a 
reciprocal tendency in modulating the flexibility of the DNA structure, meant as thermal 
stability, cation recognition, multiple conformational co-existence, etc. 
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However, our principal aim was pointed to dissect and clarify the minimal structural 
elements required to properly retain and enhance the target affinity. By a multi-approach 
analysis of the protein-DNA interaction we were able to clearly identify some fundamental 
aspects of the binding. 
Firstly, a minimal amount of negative charges (given by the phosphate backbone) has to be 
maintained in the structure, suggesting an substantial contribution of charge-charge 
interactions to the binding event. In line, an extended linear charged portions protruding 
from the G4 core irrespectively of its pairing grade, thought influencing largely the 
conformation adopted, does not affect both the thrombin binding recognition process and a 
common preferences for exosite II, as emerged by the multiple competition assays. 
Additionally, by joining 29hTBA partially paired motifs into 15fTBA, a remarkable and 
peculiar affinity profile emerged. From the EMSA binding profiles and the displacement 
study we can suppose that this 15f/29hTBA hybrid aptamer binds the target on an 
unusual/novel recognition site.This site is apparently poorly affected by ionic strength. Thus 
showed further it does not involved the highly charged exosite I and exosite II. To conclude, 
we identified a structural model consisting of a G-quadruplex core able to orient the other 
flexible elements and a flanked region unnecessarily paired that should bring a precise 
number of negative charges. Additionally, early results indicate that the molecular plasticity 
of aptamers appears to have a primary role in promoting the affinity to the target. This 
flexibility could be described by multiple parameters such as its ability to undergo toward 
structural equilibria, the thermal stability of those structures and the tendency to recognize 
and accommodate in a proper way different cations. All these aspects define the ability of 
DNA sequence to adapt its surface toward the target during the recognition process. All the 
previous concepts could represent important structural findings for the rational design of 
new modified aptamers for use in anticoagulant therapies. 
 
The data included in the sections 3.3.2 and 3.3.3 have been published:  
G. Marson, M. Palumbo, S. Claudia; Structural and functional characterization of thrombin 
binding aptamer minor loop. International Review of Biophysical Chemistry (I.RE.Bi.C.). 
2011; 2 (3) 
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4. Role of the loops on G-quadruplex flexibility 
 
4.1 Introduction 
 
Among G-quadruplexes, variation in loop length and composition affects quadruplex 
topology, stability and the already underlined molecular recognition. [14, 92, 100] 
To better define this issue we investigated the role of the loops on the structural features 
taking advantage of the use of a specific chemical probe, the anticancer cisplatin [cis-
PtCl2(NH3)2] (Fig. 4.1). 
 
 
Fig. 4.1: Chemical structure of Pt-complex, we adopted as chemical probe. 
 
Pt(II) compounds efficiently form stable DNA adducts with a preference for guanine (N7 of 
dG) and to a lesser extent for adenine (N1 and N7 of dA) through a mechanism that involves 
one or two spatially closed residues. [105] Obviously, the specific conformational feature of 
its target DNA sequence plays a prominent role in modulating the accessibility of this metal-
based chemotherapeutic. For instance, in the G-quadruplex template all guanine residues are 
paired in Hoogsteen bonds, with the nitrogen atoms at position 7 involved in hydrogen 
bonding and thus not suitable for platination.  
Indeed, it has been confirmed that G4 folded conformation could drive the reactivity toward 
another base residues (inside loop motifs). Thus, G4 folding can protect the DNA from 
metal-mediated modification. [106, 107] 
In particular, G4 can promote Pt reactivity toward other residues in comparison to 
guanosines (mainly adenosine) that are more assessable, being located in the loops.[108] 
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However, if we look at this property from the opposite point of view, platination can 
represent a valid strategy to assess the relevant folding polymorphisms (un/folding 
equilibrium for a target G-structure). 
To properly assess the Pt-driven conformational tenability, two DNA sequences attracted 
our attention, since according to their loop they could be differentially recognize by 
chemical probes. In particular here we tasted the 15 nt thrombin binding aptamer (15fTBA) 
[55] and the bombyx mori telomeric sequence (BMT).[109]  
These DNA sequences were selected according to precise requisites: their g4 structures have 
been solved by NMR studies and a similar antiparallel intramolecular G-quadruplex 
structure formed by two-layer G-tetrad core and three edgewise loops at saturating 
concentrations of K
+
 ions has been proposed for both. [67, 110] 
To fulfill the above requirements the used BMT sequence was mutated in comparison to the 
wild type sequence, in particular an U substituted the T at position 16. This mutation has 
been shown to favor the folding of the sequence into a single G-quadruplex form.[110] 
 
 
Figure 4.2: Schematic representations of the oligonucleotides studied 
 
Despite a similar three dimensional arrangement 15fTBA and BMT they vary for loop 
nature and composition, thus represent two similar but distinct systems suitable for a deep 
analysis of loop influence on DNA plasticity. Indeed, two distinct platination site patterns 
are present in the loops: A2, A7, A12 and A17 (thus, only adenosines) for the BMT and G8 
for the 15fTBA, therefore defining two optimal comparative systems for the specific 
experimental analysis we are going to perform.  
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We wondered to point out if these minimal structural variations can largely influence the 
conformational fluctuations in the quadruplex conformers occurring at different platinum 
conditions. 
 
4.2 Materials and Methods 
 
4.2.1 Materials 
 
HPLC purified oligonucleotides were purchased from Eurogentec (Serain, Belgium) as 
lyophilized powder and solubilized in 10 mM Tris, 1 mM EDTA, pH 7.4. Oligonucleotide 
concentration was determined by UV absorbance at 260 nm. Before each experiment, DNA 
solutions were heated up to 95°C for 5 minutes and slowly cooled down at room temperature 
overnight in the required buffer. Stock solution of cis-Pt-complex was prepared in MilliQ 
water and stored at -20 °C in the dark. 
 
15fTBA 
BMT 
5’- GGTTGGTGTGGTTGG -3’ 
5’- TAGGTTAGGTTAGGTUAGG -3’ 
 
Table 4.1: Sequences reported for oligonucleotides studied.  
 
4.2.2 Methods 
 
Circular dichroism (CD). Circular dichroism spectra from 230 to 320 nm were recorded 
using 10 mm path length cells on a Jasco J-810 spectropolarimeter equipped with a Peltier 
temperature control system in 10 mM Tris-HCl, pH 7.4 containing the 85 mM KCl 
concentration. The reported spectrum of each sample represents the average of 3 scans 
recorded with 1-nm step resolution. Observed ellipticities were converted to mean residue 
ellipticity [θ] = deg x cm2 x dmol-1 (Mol. Ellip.). 
Solutions were titrated with the concentrated cisplatin solution (3.33 mM), by stepwise 
addition of aliquots until a final [Pt] of 500 µM. 
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Time driven CD spectra were recorded regularly within 28 hours of incubation at 25 °C in 
the presence of a 1/10/100 molar excess of the metal complex probe. 
 
Adduct formation on distinct DNA sequences. Single- stranded 5’-fluorescein labeled 
1fTBA (µM) was incubated at increasing concentrations of cisplatin (in presence/absence of 
a concentration of thrombin equimolar to DNA) in order to obtain the following DNA : Pt-
complex molar ratios: 1:100, 1:10 and 1:1 at 25 °C for 28 h in 10 mm Tris, 85 mM KCl, pH 
7.5. The reaction mixtures were lyophilized, and the samples were resuspended in 5 µL 80% 
formamide containing 0.1% xylene cyanol and bromophenol blue. Denaturing gel 
electrophoresis was performed with 20% polyacrylamide gels (19:1 
acrylamide/bisacrylamide) in 1X TBE. DNA was visualized by recording the fluorescence 
emission of the fluorescein label in a Storm 840 (Amersham). 
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4.3 Results 
 
A NMR analysis of the G-4 folded form of BMT has been previously reported. By CD 
spectroscopy here we assessed if in the experimental conditions we previously used to 
characterize 15fTBA, similar structural features can be deducted. 
According to the chiroptical signature, we confirmed that the BMT sequence, at saturating 
concentration of potassium, adopts an univocal antiparallel conformation displayed by a 
broad positive peak at 292 and negative one at 262 nm, with a zero crossing at 280 nm. This 
CD pattern is fully consistent with the folding adopted by the 15nt aptamer chain (15fTBA) 
(Fig. 2.1,A). 
 
Figure 4.3: Biophysical and functional characterization of BMT sequence 
DNA (1 µM) electrophoretic mobility shift induced by increasing protein concentration  
(0; 0.45; 1.3; 5.7 and 10.8 μM) 
(B) Variation of CD spectra upon addition of KCl for BMT. CD spectra are evidenced in the 
absence (dashed line) or presence (solid line) of saturating concentrations of K
+
. 
DNA concentration 5 µM in 10 mM Tris, pH 7.4. 
The arrows indicate the variation induced by the increasing K
+
 concentrations. 
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 Kd (mM) Tm (°C) 
15fTBA 0.41 ± 0.17 48.8 ± 0.1 
BMT 7.93 ± 3.19 45.0 ± 0.2 
 
Table 4.2: Apparent K
+
 dissociation constant and melting temperatures (Tm) of tested 
aptamers determined by CD spectroscopy in buffer containing 50 mM KCl. 
 
The Kd determined for the BMT is lower respect to the one previously reported for 15fTBA. 
However, differences in the two oligonucleotide sequences does entail a notably change of 
the melting temperatures, as reported in table 4.2. This finding suggests that the thermal 
stability of pure antiparallel G4 form is barely influenced by loop nature. 
As expected and experimentally confirmed by EMSA the common structural feature of the 
two tested G4 do not grant to the BM telomeric sequence to recognize thrombin, the protein 
target of 15fTBA. 
Afterwards, circular dichroism was applied to preliminary assess if platination can cause the 
structural changes in the analogous antiparallel G quadruplex. The experiments were 
performed at K
+
 concentration of 85 mM where the full conversion into the antiparallel G-
quadruplexes form was confirmed for both sequences. 
Upon addition of increasing amounts of cisplatin, the CD spectra of the K
+
-induced 
quadruplexes did not promptly changed of the CD (Fig. 4.3.A,B). This finding is consistent 
with the literature data that indicate how the reactivity of cisplatin toward DNA is connected 
to its conversion into reactive aqua species, a slow reaction which requires few hours to be 
fully activated.[111] 
Accordingly, by increasing incubation time with the tested Pt probe, clear perturbations of 
CD signal emerged for both DNA sequences.  
However, as reported in figure 4.3, this effect is largely dependent upon cisplatin/DNA 
molar ratio. Indeed, it is maximal in the presence of a large molar excess of metal complex 
but completely absent when the ligand was added at stoichiometric ratio. 
We can assume that when the metal complex is added at stoichiometric ratio, platination 
occurs but preferentially at the reactive DNA residues located in the loop (G or A for 
15fTBA and BMT, respectively). Conversely, by increasing the metal probe concentration 
(up to hundred-fold molar excess), platination can occur also on the accessible stacked 
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guanosines, thus competing with the stabilizing hoogsten network. This competition bring to 
a time-driven disruption of the G4 structure, monitored through the variations of the CD 
spectra (Fig. 4.3.C,D). 
 
Figure 4.3: In PANELS A and B; Variation of CD spectra upon addition of cis-Pt for 
15fTBA (red line) and BMT (black line). 
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CD spectra in the absence (solid line) or presence (dotted line) of 500 equivalents of Pt ions 
are evidenced. DNA concentration 5 µM in 10 mM Tris, 85 mM KCl, pH 7.4. 
In PANELS C and D; Variation of CD spectra induced by a 1:1; 10:1; 100:1 cisplatin/DNA 
molar ratio recorded for 28 hours in 10 mM Tris, 85 mM KCl, pH 7.4 at 25 °C for 15fTBA 
(red line) and BMT (black line). 
In PANEL E; Time-driven relative variations of the CD intensities recorded at 295 nm 
induced by a 1/10/100 fold molar excess of tested cis-Pt on 15fTBA (red lines) and BMT 
(black lines) in 10 mM Tris, 85 mM KCl, pH 7.4 at 25 °C. 
 
 
However, the kinetic of platination on the G quartets determined the changes of the 
characteristic CD pattern upon incubation time. In may be not intrinsically related to the 
adduct formation. 
To overcame this intrinsic drawback of the technique we resolved by denaturing 
polyacrylamide gel electrophoresis the platinum-DNA reaction products, taking advantage 
of the availability of the fluorescein 15fTBA. This approach allows the analysis of stable 
adduct formation at single base resolution. [112] 
For the 15fTBA substrate we performed an incubation with the metal complex adopting two 
different incubation times (21 and 28 hours) in order to analyze the kinetic profile of the 
DNA adduct formation. The reaction was performed at 25 °C, in 85 mM K
+
. The results are 
reported in Figure 4.4. The gels showed a progressive decrease of the free DNA upon 
increasing Pt complex concentration which is associated to the appearance of lower mobility 
bands. These corresponds to the platinated DNA. 
Additionally, more platination events can be detected on the DNA strand occurring only at 
higher platinum conditions for both incubation times. 
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Figure 4.4: PAGE analysis of 5’-fluorescein 15fTBA (10 µM) after 21 h (PANELS A and 
B) or 28 h (PANEL C and D) incubation at 25 °C with increasing concentrations of cisplatin 
(DNA:Pt-complex molar ratios: 0; 1:1; 1:10 and 1:100) in 10 mm Tris, 85 mm KCl, pH 7.5. 
In addition,in the PAGE displayed in the PANELS B and D the reaction mixture with we co-
incubated the an equimolar concentration of human thrombin (10 µM). 
 
 
Since 15fTBA represent a protein recognition agent, we were interest in understanding how 
the simultaneous presence of the thrombin can influence the adduct formation on DNA. 
When the protein was included in the reaction mixture we observed that DNA platination 
was significantly impaired. This data can be related to a competition between S- or N- 
platination sites of the protein (Cys, Met and His) and N7 of guanine. 
Nevertheless, it can indicate that the protein bound DNA represents a poorer target for the 
metal complex. 
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4.4 Conclusions 
 
Data herein presented provide a preliminary characterization of the behavior of similar G 
quadruplex structures upon addition of cisplatin. This result was pursued in order to better 
understand how minimal differences in the structure could prevent or modulate the DNA 
flexibility given by the chemical probe. Primarily, we identified and characterized a 15fTBA 
analogous G quadruplex forming sequence BMT in order to compare two related molecular 
systems. Then, we demonstrated how the G4 folding of both sequences is disrupted by high 
platinum concentration in a time dependent manner. Apparently, the distinct platination 
pattern on the external loops that characterizes the two DNA systems seems not largely 
influence the occurrence of unfolding process. 
This is likely connected to the large excess of metal complex used to monitor it. However, it 
can be also the results of the comparable structural stability exerted by the two quadruplex. 
As future perspective it will be useful to check if less stable G4 sequences are more prone to 
be disrupted by platination. 
As far as concern data at low cisplatin DNA molar ratio by merging the preliminary 
electrophoretic results with the spectroscopic characterization of the DNA structures we can 
confirm that only a single platinum adduct is formed on the DNA templates, presumably 
involving the residue in the loops. 
In this contest it is attractive to underline how the platination reaction on the 15fTBA is 
significantly diminished in presence of thrombin. We can assume this finding as the 
consequence of the increased 15fTBA stability upon binding. Nonetheless a detailed 
competition study about potential platination sites for protein DNA mixture has to be 
performed in order to clarify the issue. The partial results could be considered relevant since 
open the question if the cisplatin represents a relative probe for mapping the accessibility of 
binding modules or conversely to assess the protein recognized, thus representing a novel 
approach to obtain highly selective diagnostic tool. 
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5. Synthesis of human nucleolin forms in Escherichia coli and its 
purification as G-quadruplex binding protein 
 
5.1 Introduction 
 
C-Myc proto-oncogene encodes for a multifunctional transcription factor that plays an 
important role in a broad range of cellular processes, including the regulation of cell cycle 
progression, cell growth, differentiation, transformation, angiogenesis, and apoptosis. [113-
116] 
Aberrant c-Myc expression is one of the hallmarks of a significant number of human 
malignancies, including breast, colon, cervix, small-cell lung cancers, osteosarcomas, 
glioblastomas, and myeloid leukemias. It has been estimated that around as one-seventh of 
all cancer deaths (70,000 deaths annually in the United States) [115] are associated with 
alteration of c-Myc expression. In contrast to other widely characterized oncogenes, such as 
the human RAS, where the primary mechanism of tumor promotion is through the 
acquisition of activating mutations, c-Myc is usually dysregulated indirectly through 
alterations of the upstream transcriptional activation pathway that leads to uncontrolled 
expression. [116] 
In fact, one crucial DNA element that has been shown to regulate c-Myc expression is 
located –142 to –115 bp upstream of the P1 promoter, and it has been shown to control up to 
90% of the total c-Myc transcription.[117] This DNA segment is highly sensitive to DNAse 
I and S1 nucleases. For this reason is referred to as the nuclease hypersensitive element 
(NHE) III1. The NHE III1 consists of a guanosine-rich sequence that can equilibrate under 
physiological conditions between transcriptionally active forms (duplex and single-stranded 
DNA) and a guanosine quartet structure that was demonstrated to act as transcriptional 
repressor element. [3, 117-119] In particular, as assessed by NMR spectroscopy, the G-
tetrad arrangement adopts an intramolecular parallel-stranded structure containing three 
G(anti)-G(anti)-G(anti)-G(anti) quartets and three side loops, in the presence of potassium 
ions. [120] 
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This conformational plasticity can be modulated by a number of proteins, different 
transcription factors that drive the passage between an inactive form of the promoter to an 
active one. 
A model proposed by Hurley et al [121] hypothesizes that human Non Metastatic 23 
isoform 2 protein (NM23-H2) triggers c-Myc transcription by unfolding G-quadruplex NHE 
III1 region to a single-stranded conformation and allowing single-stranded transcription 
factors, such as CNBP, to bind and stabilize this form. This transient single-stranded 
element could then hybridize, by adopting a duplex DNA structure, a specific substrate for 
transcription factor Sp1, which initiates c-Myc expression.[117] 
Instead, the same NHE III1 DNA sequence, when folded in a G-quadruplex arrangement, is 
recognized by nucleolin, a protein which binds and stabilizes this promoter but acting as an 
oncosuppressor and so decreasing its transcriptional activity in a G-quadruplex dependent 
way. [122-124] 
In this introduction the dynamic roles of the transcription factors involved in the modulation 
of c-Myc NHEIII1 are briefly discussed but a key concept that has to be stressed is that 
DNA conformational switch is the “cruise control” component of the overall system. The 
extraordinary feature of this on/off switch for oncogene expression can be resumed by 
considering the structural plasticity of the G-quadruplex structures, which makes them an 
attractive target for the development of selective anticancer therapeutic agents. [113, 125] 
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Fig. 5.1: Model of the different promoter forms assumed by the c-Myc promoter NHE 
III1. (modified form [117]) 
(a) Binding of nucleolin to the G-quadruplex structure leads to inactivation of c-Myc 
expression. 
(b) Binding of hnRNP K and CNBP to the single-stranded C- and G-rich regions, 
respectively, promotes the formation of double strand form inside c-Myc promoter. 
(c) Binding of Sp1 to the duplex structure leads to activation of c-Myc expression. 
 
As previously anticipated, nucleolin is the principal mammalian protein that specifically 
interacts with and drives the intramolecular c-Myc promoter to its silencer conformation. 
[123] 
This multifunctional nucleolar protein is a ~76-kDa phosphoprotein that plays a role in 
chromatin decondensation, ribosome biogenesis, cell proliferation, differentiation and 
maintenance of neural tissue and apoptosis. [122] 
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This functional versatility can be ascribed to a complex domain structure, illustrated in 
figure 5.2. 
 
Fig. 5.2: Diagram of human nucleolin protein domains.  
 
 
The N-terminal domain is constituted of repeated TPXKK motifs flanked by stretches of 
highly acidic amino acid residues contains multiple phosphorylation sites that influence the 
cellular localization. 
The central region contains four consensus RNA-binding domains (RBDs), also known as 
RRM (RNA recognition motif). A specific feature of this region is that each module is 
separated by flexible linker loops. 
The C-terminal domain called GAR or RGG domain is characterized by an abundance of 
Arg-Gly-Gly repeats interspersed with aromatic amino acids, such as phenylalanine 
residues. 
The RGG domain of nucleolin also binds RNA, but the binding is non-specific and weak. 
This modular architecture provides a higher structural versatility to the protein, since by 
combining multiple domains, nucleolin can construct various interaction surfaces which can 
be assembled and disassembled as needed.  
In addition, its plasticity allows the protein to recognize a large number of substrates. For 
example, by combining its first two RBDs, nucleolin interacts with the stem-loop RNA 
structure formed by the nucleolin recognition element, while all four RBDs are required for 
binding to a single-stranded RNA motif found in pre-rRNA. [126, 127] 
The last specific interaction of this multi-domain protein with nascent pre-rRNA and 
ribosomal proteins is thought to be important for the proper folding of pre-rRNA and its 
packaging into pre-ribosomal particles. 
Due to its modular structure, nucleolin can adapt to interact also with nontraditional forms of 
RNA and DNA, including G-quadruplex structures such the ones formed at c-Myc promoter 
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level. The specific binding with this nucleic acid target has been associated with the down-
regulation of c-Myc oncogene transcription. [123] 
The goal of this project is to develop an expression system and design a convenient 
purification protocol for producing large amount of pure protein to be used for 
crystallization studies aimed to define the G-quadruplex-binding event at molecular level. 
Our efforts are also directed toward an accurate characterization of the retained binding 
occurring between the protein construct we designed and the DNA target in order to identify 
the minimal protein modules involved in the G-quadruplex binding. 
Indeed, elucidating the nature of the interactions occurring at the binding interface of this 
transcriptional repressor complex represents a noteworthy goal in order to accelerate the 
development of new chemotherapeutic agents able to stabilize this protein-DNA complex. 
This preliminary work was carried out at Memorial Sloan Kettering Cancer Center of New 
York in the Structural Biology Laboratory of Professor Dinshaw Patel, a worldwide leading 
group for structural studies of higher-order DNA structures and epigenetics code. 
 
 
5.2 Materials and Methods 
 
5.2.1 Materials 
 
Synthetic oligonucleotides. DNA sequences and PCR primers were purchased from 
Invitrogen (Grand Island, NY, USA) as lyophilized powder and solubilized in 5 mM Tris, 
pH 8.0. Oligonucleotide concentration was determined by absorbance at 260 nm. Before 
each experiment, guanosine rich DNA solution was heated up to 95°C for 5 minutes and 
slowly cooled down at room temperature overnight in the required buffer. 
The G-rich sequence is listed in Table 5.1. 
 
c-Myc27 5’- TGGGGAGGGTGGGGAGGGTGGGGAAGG -3’ 
 
Table 5.1: G-rich sequence identified within c-Myc NHEIII1.  
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Prokaryotic competent cells. Escherichia coli chemically competent One Shot® TOP10 
(Invitrogen, Grand Island, NY, USA) and BL21 (DE3) RIL (Stratagene, Santa Clara, CA, 
USA) cells were used for gene cloning and protein expression, respectively. 
 
5.2.2 Methods 
 
Design of human nucleolin expression clones. The gene-encoding full-length human 
nucleolin was purchased from Open Biosystems (Lafayette, CO, USA, Catalogue No. 
EHS1001-3523787). The PCR selected and amplified cDNA fragments were inserted into a 
self-modified vector, which fuses an N-terminal hexa-histidine to a yeast SUMO tag to the 
target gene. 
The protein construct was designed according to the results published by Hurley et al [123] 
that highlight how the C-terminal fragment of nucleolin binds to the c-Myc promoter G-rich 
sequence. To identify the correct protein segment carrying the domain involved in the 
binding with the G-rich sequence, we analyze the primary sequence of human nucleolin 
(SwissProt entry: P19338) according to previous scientific works and using the software 
SMART, available on line at the site: http://smart.embl-heidelberg.de/ [128] 
 
 
Fig. 5.2: Nucleolin mutants 
(A) Diagram of human nucleolin protein domains.  
(B, C) Diagrams of the nucleolin mutants used in this study.  
 
 
All proteins were overexpressed in Escherichia coli fused with an N-terminus hexa-
histidine-SUMO–tag. Gene regions corresponding to our constructs were PCR amplified 
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using synthetic primers, which introduced the restriction enzyme sites BamHI (5’-
G_GATCC-3’) on the sense primer and XhoI (5’-C_TCGAG-3’) on the antisense primer for 
subcloning into our expression vector. 
The first clone corresponding to the C-terminal nucleolin (defined hNuc 3,4RRMs-RGG482-
710) was selected using as forward primer 5’-ATAGGA 
TCCAGTGGTGAATCAAAAACTCTGG-3’ and as reverse primer 5’-
TATCTCGAGCTATTCAAACTTCGTCTTCTTTCC-3’ and encodes for the protein 
fragment corresponding to amino acids 482 to the last 710 in the native sequence. The 
second clone (defined hNuc 3,4RRMs482-648) was amplified using the forward primer 5’-
ATAGGATCCAGTGGTGAATCAAAAACTCTGG-3’ and reverse primer 5’-
TATCTCGAGCTACTTAGGTTTGGCCCAGTC-3’ and encodes for the fragment 
corresponding to amino acids 482 to 648 in the full length sequence. 
The PCR reaction was carried out in a total volume of 25 µl containing 50 nmol of each 
PCR primer, 100 ng of template DNA and 22 µl of the PCR AccuPrime™ Pfx Supermix 
(Invitrogen, Grand Island, NY, USA), a commercial ready-to-use mixture of DNA 
polymerase, accessory proteins, salts, magnesium and dNTPs. 
The PCR amplification was carried out through 30 cycles of denaturing (95 °C, 30 seconds), 
annealing (55 °C, 1 minute) and elongation (68 °C, 1 minute). The final elongation step was 
at 68 °C for 15 minutes. 
The 686 bp and 500 bp PCR products containing the cDNA encoding for the two constructs 
were recovered from agarose gel electrophoresis, and subsequently purified. The purified 
PCR product was digested with BamHI and XhoI at 37 °C for 3 hours. The purified 
digestion product was then ligated into our expression vector using the SNOVA ligation kit. 
The identities of all the recombinant clones were confirmed by DNA sequence analysis. 
 
Protein purification. The plasmids were transformed into Escherichia coli strain BL21 
(DE3) RIL cells (Stratagene, Santa Clara, CA, USA).  
Transformed cells were grown at 37 °C in one liter of Luria Bertani broth (supplemented 
with 30 mg/l kanamycin and 25 mg/l chloramphenicol, respectively) until OD600 reached 
1.0, afterwards the media was cooled to 20 °C and isopropylthio-β-D-galactoside (IPTG) 
was added to a final concentration of 0.2 mM to induce protein expression overnight. 
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The cells were harvested by centrifugation at 4 °C for 12 minutes (4500 g) and resuspended 
in buffer A (500 mM NaCl, 25 mM Tris pH 8.0 and 20 mM imidazole) supplemented with 1 
mM phenylmethylsulphonyl fluoride (PMSF) as protease inhibitor and 2 mM β-
mercaptoethanol (β-ME). 
After the cells lysis performed on ice using the french press high-pressure homogenizer the 
insoluble cell debris was removed from the cell lysate by centrifugation at 4 °C for 90 
minutes (16000 g). 
Subsequently lysate was purified by immobilized metal affinity chromatography (IMAC) by 
loading the supernatant onto two nickel loaded HisTrap FF crude columns (GE Healthcare, 
Little Chalfont, Buckinghamshire, UK). 
After extensive washing by buffer A, the target protein was eluted with buffer A 
supplemented with 300 mM of imidazole. 
High imidazole concentration was removed by dialyzing the eluate at 4 °C overnight against 
one liter of buffer A. 
The hexa-histidine-SUMO tag was cleaved by Ulp1 protease at room temperature and 
removed by further passing through a second step of HisTrap FF column. 
From this point the purification of the two different recombinant nucleolin forms diverged, 
relying on an ion exchange chromatography (IEC) carried out with Q Sepharose columns 
(GE Healthcare, Little Chalfont, Buckinghamshire, UK) and a buffer B pH 8.0 for hNuc482-
648, instead an ion exchange chromatography (IEC) carried out with HiTrap heparin HP 
columns (GE Healthcare, Little Chalfont, Buckinghamshire, UK) and a buffer B pH 8.0 for 
hNuc482-710, according to the different physicochemical parameters of the two proteins. 
The protein was dialyzed with a 10 kDa MWCO Cut off membrane the eluate at 4 °C 
overnight against one liter of buffer B (150 mM NaCl, 20 mM Tris and 5 mM Dithiothreitol 
(DTT). 
Subsequently the construct was purified by ion exchange chromatography (IEC) by loading 
the protein with the corresponding buffer B onto two 5 ml IEC columns. 
Then, the protein was eluted with a linear gradient (50%/50 min) from the loading buffer B 
(150 mM sodium) to the elution buffer (2 M NaCl, 20 mM Tris) at 2.5 ml/min flow rate. 
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Both protein samples were concentrated using an Amicon Ultra-15 centrifugal filters 
(Millipore, Billerica, MA, USA) with a 10 kDa MWCO Cut off membrane to a final volume 
of 1 ml and the ionic strength of the solution was decreased to 150 mM sodium chloride. 
The pooled target protein was further purified by gel filtration using a Hiload Superdex 
G200 16/60 column (GE Healthcare, Little Chalfont, Buckinghamshire, UK) with buffer B 
(at pH 7.5 for hNuc482-710 and pH 8.0 for hNuc482-648) at 1.0 ml/min flow rate. 
HNuc482-648 was further purified by ion exchange chromatography (IEC) by loading the 
protein with buffer B pH 7.0 onto two 5 ml HiTrap heparin HP columns (GE Healthcare, 
Little Chalfont, Buckinghamshire, UK). Then, the protein was eluted with a linear gradient 
(50%/50 min) from the loading buffer (150 mM sodium) to the elution buffer (2 M NaCl, 20 
mM Tris pH 7.0) at 2.5 ml/min flow rate. 
Finally, purified proteins were concentrated to a concentration of 30 mg/mL in 150 mM 
NaCl, 20 mM Tris pH 7.0 and 5 mM DTT using an Amicon Ultra-15 centrifugal filters 
(Millipore, Billerica, MA, USA) with a 10 kDa MWCO cut-off and finally stored at -80 °C. 
Each purification step was performed by liquid chromatography using an ÄKTA FPLC 
apparatus (GE Healthcare, Port Washington, NY, USA) equipped with a P-1 pump (GE 
Healthcare, Port Washington, NY, USA) for loading large sample volumes and with a 
Frac_900 fraction collector (Amersham Pharmacia Biotech /GE Healthcare, Port 
Washington, NY, USA). 
 
Characterization of purified recombinant nucleolins. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was performed at each stage of the 
purification process to check for the purity of the recombinant protein. Purified nucleolin 
was analyzed by SDS PAGE, using NuPAGE® 4-12% Bis-Tris precast gels (Invitrogen, 
Grand Island, NY, USA) and visualized with Coomassie blue R-250 staining. 
SDS gel images were captured using Epson 4990 photo scanner. 
The final concentration of total protein was determined by UV absorbance at 280 nm on a 
single beam model NanoDrop 2000c from Thermo Scientific (Waltham, MA, USA). 
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ITC measurements. Protein sample and G-rich DNA sequence used for ITC measurements 
were dialized overnight dialysis against buffer containing 20 mM HEPES pH 7.0 and 50 
mM KCl. 
Before each measurement, the protein concentration was adjusted to about 0.1 mM. 
ITC measurements were carried out at 0.1 mM protein concentration and 1.5 mM nucleic 
acid concentration on an ITC200 Microcal calorimeter (MicroCal, Piscataway, NJ, USA) at 
25 °C. 
A typical titration consisted of 17 injections of 2.4 µl of DNA solution into the protein 
solution at time intervals of 180 seconds. 
Binding constants were calculated by fitting the data using the ITC data analysis module of 
Origin 7.0 (OriginLab Corporation) using the 1:1 binding model. 
 
Computational methods. The in silico estimation of proteins physical and chemical 
parameters, such as theoretical pI value, molecular weight and extinction coefficients, was 
performed using the software Protparam, available on line at website: 
http://web.expasy.org/protparam/ [129] 
 
The computational sequence analysis aimed to rapidly identify the modular architecture of 
the protein, was carried out using the Web-based tool SMART, available on line at the 
website: http://smart.embl-heidelberg.de/ [128] 
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5.3 Results 
 
5.3.1 Purification of recombinant human nucleolin forms 
 
The design of an optimized expression vector and purification protocol, aimed to obtain 
multi-milligram quantities of highly purified (~95% purity) protein, represents a compulsory 
step in structural biology field. 
Several scientific papers highlight the impossibility to obtain full-length nucleolin 
expression in E. coli. [124] For this reason, according to the resources available in the 
laboratory, we attempt to engineer the target protein by deleting the N-terminal segment but, 
at the same time, trying to maintain in the resulting construct the functional domains 
involved in G quadruplex binding. To express our recombinant protein we used a vector 
which drives the expression of the recombinant gene under the control of the T7 RNA 
polymerase promoter and lac operator. 
Since both the recombinant proteins were engineered to contain an N-terminal hexa-
histidine-SUMO -tagged, immobilized metal affinity chromatography (IMAC) on Nickel 
Sepharose FF was devised as the initial capture step. 
Figures 5..3A.1 and 5.3.B.1 show the capture steps by IMAC of both recombinant nucleolin 
forms.  
An evident additional peak, which eluted at high imidazole concentration indicates an 
effective separation from the untagged proteins produced by the prokaryotic system not 
bound to the metal loaded in the column. 
The molecular weight of the two fragments, predicted in silico by amino acid composition, 
is 24,160 Da for hNuc482-710 and 18,369 Da for hNuc482-648, respectively. 
SDS page analysis (Fig. 5.3.A.2 and 5.3.B.2) was used to check the effective separation 
from the untagged proteins produced by the prokaryotic system before (+) and after (*) the 
excision of the 6His-SUMO tag (around 11.5 kDa) with Ulp1 protease treatment. 
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The molecular weight of the expressed samples was approximated to the migration distance 
relative to the protein marker. 
 
Fig. 5.3 
In PANEL A.1; IMAC of polyHis-SUMO tag hNuc482-710 on Ni
++
 HisTrap. 
In PANEL B.1; IMAC of polyHis-SUMO tag hNuc482-648 on Ni
++
 HisTrap. 
Buffer A and B contained 20 mM and 500 mM imidazole. The polyHis-SUMO tagged 
recombinant protein was eluted in the last visible peak at 100% solvent B.  
In the PANELS .2 all the corresponding SDS page analysis are displayed. 
An asterisk is placed under the lane referring to the sample taken after adding the Ulp1 
protease. 
A cross is placed under the lane corresponding to chromatographic peak. 
For each control gel we reported molecular mass markers (mass values are reported). 
 
 
Although the IMAC procedure sometimes is indicated as a successful single-step 
purification technique of heterologous proteins, RNA/DNA binding proteins often require 
more purification steps to remove the host RNA or DNA, strongly bound during 
overexpression, in order to achieve the desired level of product purity and so to maximize 
the chances of obtaining protein crystals. 
Polishing of recombinant nucleolin constructs were successfully accomplished by iterative 
ion exchange and gel filtration chromatography passages. 
Ion exchange chromatography (IEC) was adopted as convenient intermediate purification 
technique. 
Protein separation by IEC is primarily dependent on the charge properties of the proteins so 
the first step in establishing a suitable IEC purification consists of the identification of the 
conditions allowing efficient binding (and elution) of target protein to the columns matrix. 
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According to the calculated isoelectric points of the constructs (9.25 for hNuc482-710 and 4.96 
for hNuc482-648) and in order to optimize the resolving power of this chromatographic 
technique we decided to use HiTrap heparin HP columns and a buffer pH 7.5 for hNuc482-710. 
At the same time, the Q Sepharose column associated to a loading buffer pH 8.0 was 
considered more suitable for purification of hNuc482-648.  
During IEC, nucleolin482-710 displayed a strong affinity for the charged groups of the column, 
as much as to finally get the protein we needed to increase the ionic strength of the elution 
buffer to a maximum value. (Fig. 5.4.A.1) 
A further necessary purification step for both forms was carried out through size-exclusion 
chromatography, often recommended to detect and remove any high-molecular-weight 
aggregates or persisting trace contaminants.  
The gel filtration purification outlined two distinct behaviours for the recombinant proteins.  
For hNuc482-710 the purified fraction was displayed by a low and asymmetric 
chromatographic peak (Fig. 5.4.B.1), suggesting a final product extremely impure. 
Furthermore the protein in the pooled samples demonstrates the tendency to precipitate. 
The instability evidenced by hNuc482-710 points out how this protein does not represent a 
suitable candidate for protein-crystallization trials. 
Conversely, the shorter hNuc482-648 was eluted as a single symmetric sharp peak (Fig. 
5.4.D.1) and reasonably well separated from contaminants. 
However the peak referring to the shorter recombinant protein is still marked by a high 
A260/A280 ratio (Fig. 5.4.D.1) which indicates a residual presence of a nucleic acid fraction 
bound to the protein. 
According to the previous finding the final purification of hNuc482-648 was obtained by a 
second IEC analysis, conducted at lower pH conditions (pH 7), chosen to alter the charge of 
the protein, and with a different ion exchange column (HiTrap Heparin). 
This polishing step (Fig. 5.4.E) ultimately led to the achievement of a pure recombinant 
nucleolin482-648. Indeed, the corresponding SDS–PAGE analysis (Fig. 5.4.E.2) of the fraction 
confirms the homogeneity of the final product. 
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Fig. 5.4: 
In PANEL A.1; IEC of hNuc482-710 on HiTrap heparin HP. 
In PANEL B.1; Gel filtration of hNuc482-710 on Hiload Superdex G200 16/60. 
In PANEL C.1; IEC of hNuc482-648 on Q Sepharose. 
In PANEL D.1; Gel filtration of hNuc482-648 on Hiload Superdex G200 16/60. 
In PANEL E.1; IEC of hNuc482-648 on HiTrap heparin HP. 
In the PANELS X.2 are displayed all the corresponding SDS page analysis. 
A cross is placed under the lane corresponding to chromatographic peak. 
For each controlling gel we reported molecular mass markers (mass values are reported). 
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The estimation of the final yield for hNuc482-648 was done by measuring the UV absorbance 
at 280 nm of the pooled fraction adopting as extinction coefficient the value of 8,480 M
-1
 
cm
-1
, previously calculated in silico from the hNuc482-648 amino acids composition as 
described in materials and methods. 
Finally, the discrete value of 1.3 mg/liter of recombinant hNuc 3,4RRMs 482-648 was obtained 
adopting this multistep protocol. 
 
  
5.3.2 ITC-based binding affinities for complex formation 
 
In a paper of 2009, Hurley stated that C-terminal domain of human nucleolin, composed by 
the last two RBDs domains and the terminal RGG motif, still maintained the binding to the 
c-Myc G-quadruplex promoter with high affinity and selectivity and proved that by different 
biochemical techniques such as EMSA and fluorescence melting. [123] 
In this work we decided to attest the binding affinity of the shorter protein construct that we 
previously expressed and purified, to the oncogene promoter by means of ITC, a very 
sensitive calorimetric technique which allows defining the thermodynamic properties of the 
binding event. 
The analysis of the curve obtained indicates that, surprisingly, hNuc482-648 is also able to 
interact with the 27mer G-rich sequence with a binding affinity of about 17.3 µM, a value 
around six-fold lower if compared to the dissociation constant calculated by Hurley.[123] 
Without focusing on the difference of affinity, which can be due to the different techniques 
adopted, we found that the third and the fourth RNA binding domains of nucleolin are still 
able to recognize the physiological G-quadruplex target.  
A detailed analysis of the thermodynamic properties of the binding events indicates that the 
complex formation is predominantly of enthalpically driven (ΔH = -14.31 kcal/mol) and is 
partially compensated by an entropic contribution (-TΔS = 7.676 kcal/mol). This 
thermodynamic signature is consistent with additional electrostatic forces and hydrogen 
bonds presumably at the binding interface associated to conformational restrictions of the 
side chains and nucleobases flexibility upon complex formation. 
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Obviously this hypothesis should be confirmed by consistent structural results which can 
prove the formation of stabilizing interactions at the interface of the complex. 
 
 
Fig. 5.5: Quantification of the binding affinity between hNuc482-648 and c-Myc 27mer DNA 
sequence. 
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5.4 Conclusions 
 
To conclude, we developed a highly reproducible purification protocol which, although 
yielding only about 1.3 mg of pure recombinant nucleolin 3,4RRMs 482-648 per liter culture, 
lets us to obtain an extremely pure protein. This is a very important feature for 
crystallographic studies. 
The protein product appears remarkably stable and the lack of precipitation or aggregation 
makes it a good candidate for structural studies. 
In addition, the construct we design (a 166 amino acid sequence containing the 3,4 RNA 
binding domains) maintains a good selectively toward the nucleic acid target as evidenced 
through the accurate calorimetric analysis of the binding performed by ITC. 
This finding delves into the previous study about the correlation between nucleolin structure 
and the retained Gq binding activities and indicates that the C-terminal RGG domain is not 
necessary for the recognition event. 
The future efforts could be directed toward the characterization of the nucleolin binding 
toward other G-quadruplex forms, differing from the parallel one adopted by the c-Myc 
promoter. 
Our preliminary but noteworthy results combined to the absence of a solved structure of 
protein-DNA complex encourage us to improve our efforts to set up the best crystallization 
conditions in order to solve the three dimensional structure of the complex. 
Decrypting the structural insights of this complex, so embedded in the tumorigenesis 
pathway, would represent a successful starting point for further rational design of effective 
chemotherapeutics. 
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6. Recognition of unmethylated H3K4(1-10) by Arabidopsis thaliana 
origin recognition complex 1b: a functional and structural analysis of the 
complex 
 
6.1 Introduction 
 
The original concept in molecular biology that histone proteins are only static building 
blocks aimed to package eukaryotic DNA into repeating nucleosomal units is definitely 
overcame. It is now clear that histones are integral and dynamic components of the 
machinery responsible for regulating gene transcription. [130-132] 
Histone proteins take part of the control of gene expression mostly through a complex 
balance of various epigenetic modifications occurring at N-terminal sequences, including 
acetylation, phosphorylation, methylation, ubiquitination and ADP-ribosylation (Fig. 6.1). 
[133-135] 
Fig. 6.1: Model for nucleosome modifications. 
This nucleosome core particle shows the histone globular region and histone terminal tail 
that protrude through the DNA wrapped. Schematic representation of condensed 
nucleosome modifications is reported and includes acetylation (ac), phosphorylation (p), 
methylation (me) and ubiquitination (u). Residue numbers are included for each 
modification. 
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The modification pattern of histone tails, which protrude from the surface of the 
nucleosome, may serve as a mark to be recognized by a complex and by a dynamic network 
of players such as transcription factors or remodelling chromatin elements. 
Such non histone elements are often defined by multiple protein reader domains that, 
advisably combined, can decipher the language of the histones to specific biological 
outcomes. [136] 
In particular, methylation of selected lysine (K) residues in the N-terminal tails of histones 
H3 and H4 is recognized as an important component of an epigenetic indexing system, 
demarcating transcriptionally active and inactive chromatin domains. [137, 138] 
Interestingly, the same chemical moiety can bring to distinct downstream events, for 
examples lysine methylation at H3K4, H3K36 and H3K79 marks transcriptionally active 
chromatin, whereas methylation of H3K9, H3K27 and H4K20 defines repressed chromatin 
domains. 
The discovery of specific effector proteins, such as BHC80, that bind selectively to the 
unmodified H3K4, suggested that even the absence of post-transcriptional modification 
could represent a peculiar pattern in the ‘histone code’. [139] 
In particular, methylation state of H3K4 is proposed to have a pivotal role in 
de/condensation of chromatin by serving as a binding platform for different silencing and 
transcription promoting factors. [140, 141] 
Understanding the mechanisms used by downstream effectors to recognize and transduce 
H3K4 different methylation patterns into specific gene expression “routes” constitutes to an 
intriguing challenge in epigenetic, engaging a plethora of different areas ranging from 
molecular biology and genetics to molecular pathology and oncogenesis. 
As previously discussed, the epigenetic network that comprises a complex histone code and 
a large number of effector proteins is still unclear, however the development of refined 
biochemistry techniques such as chromatin immunoprecipitation (ChiP) and the accurate use 
of specific model organism is increasingly clarifying the dynamic role of the elements that 
characterizing the obscure universe of epigenetics. 
The flowering plant Arabidopsis thaliana has been a pioneer model to explore the 
epigenetics of multicellular organisms, thanks to a compact, almost fully sequenced genome 
and a comprehensive set of genetic and genomic resources. Moreover, because 
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the Arabidopsis genome contains a large repertoire of transposable element families (but all 
in relatively few copies), the chromatin state of these ubiquitous components of the genomes 
has been assessed with great precision. [142] 
Different eukaryotic regulators are known to play a role in heterochromatin assembly and 
between those non histone epigenetic proteins an emerging role has been assigned to origin 
recognition complex (ORC). 
This protein is an evolutionarily conserved six-subunits heteromeric complex mainly known 
for its function in DNA replication. [143] 
The most studied feature of ORC is its role in binding directly to replication origins and 
recruiting cell division cycle (CDC) 1, 6 and mini chromosome maintenance proteins (Mcm) 
2-7 to form pre-replication complexes (pre-RCs) at G1/S boundary. [143] 
Moreover, ORC plays an important role in the transcriptional modulation through multiple 
interactions with heterochromatin factors such as silence information regulator 1 (Sir1) in 
budding yeast [144]and heterochromatin protein 1 (HP1) in higher eukaryotes. [144] 
Mutations across ORC subunits in multicellular organisms are associated to pleiotropic 
phenotypes that include chromosomal abnormalities and cell cycle arrest. 
As explained, the same protein complex complies with replication and transcriptional 
regulation function with an unknown mechanism that remains an intriguing issue to be 
uncovered. Accordingly, our goal consists of clarifying, by means of structural evidences, 
how Arabidopsis ORC1b, the large subunit of the origin recognition complex, can act in 
chromatin remodeling through a peculiar histone recognition process.  
An intriguing biochemical feature of plant ORC1s is represented by the presence of two 
adjacent well defined domains (a BAH domain associated to the PHD finger) [145] that 
make it a prominent subject to be investigated in order to define how different binding 
modules can resemble to achieve a specific function. 
 
 
 
Fig. 6.2:  Schematic diagram of Arabidopsis thaliana ORC1b protein domains. 
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In this section we provide an epigenetic model which shows, with structural and functional 
evidences, how Arabidopsis thaliana ORC1b is able to recognize a decapeptide 
corresponding to unmethylated H3K4 tail, according to specific protein architecture 
constitutes by a BAH-PHD cassette. 
The functional data, collected by isothermal titration calorimetry (ITC) fully confirm the 
plain reliability of the tree dimensional model and the selectivity of the atORC1b BAH-PHD 
cassette toward the H3K4 decapeptide in its demethylated form. 
My contribution to this work, conducted at Prof. Patel Lab, was mainly focused on the 
protein expression and purification of the atORC1b BAH-PHD cassette in conjunction of the 
bioinformatics and biophysical characterization of the protein product features.  
 
 
6.1.1 PHD and BAH domains, molecular architecture and functions 
 
In order to fully understand the molecular architecture of the protein-peptide complex we 
solved in this section I should briefly described the structural elements that are combined to 
form PHD-BAH cassette. 
The PHD finger is a small zinc-binding motif, characterized by a specific Cys4-Hys-Cys3 
pattern, corresponding to a C-X1-2-C-X9–21-C-X2–4-C-X4-5-H-X2-C-X12–46-C-X2-C consensus 
sequence of approximately 50-80 amino acids, where the 8 underlined residues coordinate 
two Zn
2+
 ions.[145-147] 
The arrangement of cysteine, histidine and other neighborhood residues distinguishes this 
domain from similar zinc-binding motifs as Cys3-His-Cys4 RING finger and Cys2-His-Cys5 
LIM domain.[148] 
The name PHD finger come from the cysteine-rich regions of the two closely related plant 
homeo domain proteins, HAT3.1 of Arabidopsis thaliana and Zmhox1a of maize.[149] 
In animals PHD fingers are found in transcriptional regulators often involved in chromatin-
remodelling such as the co-activators p300 and CBP, polycomb-like protein (PC), Trithorax-
group proteins like ASH1L, ASH2L and MLL, the autoimmune regulator (AIRE), Mi-2 
complex (part of histone deacetylase complex) and the co-repressors TIF1, the newly 
discovered JARID1-family of demethylases and many more.[145] 
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In the last five years, PHD fingers have emerged as protein motifs that specifically recognize 
histone H3 N-terminal tail. Two distinct subclasses of PHD fingers have been identified, 
which can specifically bind to either methylated (for example, bromodomain PHD finger 
transcription factor [BPTF] and inhibitor of growth family 2 [ING2] ) or unmethylated 
lysine residues on the histone H3 N-terminal tail. [150, 151] 
The last peculiar recognition process of unmethylated H3K4 was assessed for the 
BHC80 protein, which cooperates with lysine-specific histone demethylase (LSD1). [139] 
The second motif, the BAH (bromo adjacent homology) motif was found in eukaryotic 
DNA (cytosine-5) methyltransferase, the origin replication complex (ORC1) and several 
proteins involved in transcriptional regulation.[152] 
The BAH domain appears to act as a protein-protein interaction module specialized in gene 
silencing, as suggested for example by its interaction within yeast Orc1p with the silent 
information regulator Sir1p.[153] The BAH module might has suggested to play an 
important role by linking DNA methylation, replication and transcriptional regulation.[152] 
The features of the BAH domain can be clearly resumed with the following: preceded or 
followed by non-globular regions; found at the NH2-terminus of some proteins (e.g. N- 
terminus of human Orc1 proteins) and immediately followed by well defined modules such 
as PHD fingers (e.g. receptor-like protein ES43 of barley or ASH1 of drosophila).[145] 
The functional relevance of this last feature is still unknown, even if represents a nodal point 
highlighting if with the multiple presence of those motifs emerges a new activity due to this 
peculiar combination.  
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6.2 Materials and Methods 
 
6.2.1 Materials 
 
Synthetic peptide and oligonucleotides. DNA sequences and PCR primers were purchased 
from Invitrogen (Grand Island, NY, USA) as lyophilized powder and solubilized in 5 mM 
Tris, pH 8.0. Oligonucleotide concentration was determined by absorbance at 260 nm. The 
H3 1-10 peptide (table 6.1), (un-, mono-, di- or tri-methylated on lysine 4) used in the 
preliminary studies and in the crystallization trials were generously supplied by the group of 
Steven Jacobsen as lyophilized powder and then solubilized with DI water. 
 
H3(1-10) ARTKQTARKS 
 
Table 5.1: Decapeptide that mimicries the N terminal of the histone 3. The lysine 4, subject 
of the modifications is evidenced in bold. 
 
 
Prokaryotic competent cells. Escherichia coli chemically competent One Shot® TOP10 
(Invitrogen, Grand Island, NY, USA) and BL21 (DE3) RIL (Stratagene, Santa Clara, CA, 
USA) cells were used for gene cloning and protein expression, respectively. 
 
6.2.2 Methods 
 
Protein expression and purification. The PCR-amplified cDNA fragment of arabidopsis 
thaliana ORC1b encoding the BAH-PHD cassette (residue 126-346) was cloned into the 
self-modified expression vector and Glutatione S-transferase (GST)-tagged protein was 
overexpressed in Escherichia coli strain BL21 (DE3) RIL cells (Stratagene, Santa Clara, 
CA, USA)  
111 
 
Fig. 6.3: Schematic diagram of the atORC1b fragment analyzed in this study. 
 
Transformed cells were grown at 37 °C in one liter of LB media (containing 30 mg/l 
kanamycin and 25 mg/l chloramphenicol, respectively) supplemented with 0.1 mM ZnCl2 
until OD600 reached 1.0, then the media was cooled to 20 °C and isopropylthio-β-D-
galactoside (IPTG) was added to a final concentration of 0.2 mM to induce protein 
expression overnight. 
The cells were harvested by centrifugation at 4 °C for 12 minutes (4500 g) and resuspended 
in buffer A (250 mM NaCl, 20 mM Tris pH 7.5) supplemented with 1 mM 
phenylmethylsulphonyl fluoride (PMSF) as protease inhibitor and 2 mM β-mercaptoethanol 
(β-ME) to reduce oxidation damage.  
After cells lysis on ice by high-pressure homogenizer (French press) the insoluble cell debris 
was removed from the cell lysate by centrifugation at 4 °C for 90 minutes (16000 g). 
Subsequently lysate was purified by affinity chromatography, loading the supernatant onto 
two 5 ml GSTrap FF columns (GE Healthcare, Little Chalfont, Buckinghamshire, UK). 
After extensive washing by buffer A, the target protein was eluted with buffer A 
supplemented with 20 mM reduced glutathione. 
The GSH tag was cleaved by prescission protease at room temperature. The digestion 
mixture was dialyzed at 4 °C overnight against one liter of buffer B (150 mM NaCl, 20 mM 
Tris pH 8.0 and 5 mM Dithiothreitol (DTT)). 
Subsequently the protein was purified by ion exchange chromatography (IEC) by loading 
the protein with buffer B onto two 5ml HiTrap Q FF columns (GE Healthcare, Little 
Chalfont, Buckinghamshire, UK).  
Then, the protein was eluted with a linear gradient (50%/50 min) from the buffer B (50 mM 
sodium to the elution buffer (2 M NaCl, 20 mM Tris pH 8.0) at 2.5 ml/min flow rate. 
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Protein samples were concentrated using an Amicon Ultra-15 centrifugal filter (Millipore, 
Billerica, MA, USA) with a 10 kDa MWCO Cut off membrane to a final volume of 1 ml 
and the ionic strength of the solution was decreased to 150 mM sodium chloride. 
The pooled target protein was further purified by gel filtration using a Hiload Superdex 
G200 16/60 column (GE Healthcare, Little Chalfont, Buckinghamshire, UK) with buffer B 
at 1.0 ml/min flow rate. 
Finally, the purified proteins were concentrated to 15–20 mg/mL in 150 mM NaCl, 20 mM 
Tris pH 8.0 and 5 mM DTT using an Amicon Ultra-15 centrifugal filter (Millipore, Billerica, 
MA, USA) with a 10 kDa MWCO Cut off membrane. 
Every purification step was performed by liquid chromatography using an ÄKTA FPLC 
apparatus (GE Healthcare, Port Washington, NY, USA) equipped with a P-1 pump (GE 
Healthcare, Port Washington, NY, USA) for large sample volumes loading and with a 
Frac_900 fraction collector (GE Healthcare, Port Washington, NY, USA).  
 
Crystallization and Synchrotron Data Collection. In order to obtain the crystallization of 
Origin Recognition Complex 1b BAH-PHD with unmethylated H3K4 decapeptide, the protein 
was concentrated to 15 mg/ml and mixed with peptide in molar ratios of 1:5 at 4 °C for 1 hr. 
Crystallization was carried out at 20 °C using the hanging drop vapor diffusion method by 
mixing 1.5 µl of protein-peptide complex sample with 1.5 µl reservoir solution.  
The crystallization conditions were initially identified using the following sparse-matrix 
screen kits: JCSG I, II, III, IV, Compas and PACT (Hampton Research), screening in total 
576 crystallization conditions. 
Several conditions yielded crystallization of the complexes within several days.  
Then the crystals were directly mounted on a nylon loop for diffraction data collection. 
X-ray diffraction data set for H3(1–10)K4me0-bound to atORC1bBAH-PHD domain were 
collected at zinc peak wavelength on the X29A, National Synchrotron Light Source (NSLS) 
at Brookhaven National Laboratory (New York, NY, USA). 
The diffraction data were indexed, integrated and scaled using the HKL 2000 program. The 
structure of free atORC1bBAH-PHD was solved by the single-wavelength dispersion method 
with zinc atoms using the AutoSol program embedded in PHENIX software, which also 
gave an initial structural model. 
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Further modeling of atORC1bBAH-PHD domain was carried out using COOT, and then refined 
using PHENIX. The final model was refined to 1.9 Å resolution. 
 
ITC measurements. Protein samples used for ITC measurements were subjected to 
overnight dialysis against buffer containing 150 mM NaCl, 20 mM Tris (pH 7.5) and 2 mM 
b-mercaptoethanol. 
Extensively lyophilized H3 1–10 peptides (un-, mono-, di- or tri-methylated on lysine 4) 
were dissolved in the same buffer. 
Before each measurement, the protein concentration was adjusted to about 0.1 mM. 
ITC measurements were carried out from 0.1 mM protein concentration, with 1.5 mM 
peptide concentration, on an ITC200 Microcal calorimeter (MicroCal, Piscataway, NJ, 
USA) at 25 °C. 
A typical titration consisted of 17 injections of 2.4 µl of DNA solution into protein solution 
at time intervals of 180 s. 
Binding constants were calculated by fitting the data using the ITC data analysis module of 
Origin 7.0 (OriginLab Corporation) with a 1:1 binding model. 
 
Computational methods.  
The computational sequence analysis, aimed to rapid identifies modular architecture was 
carried out using the Web-based tool SMART, available on line at the website: 
http://smart.embl-heidelberg.de/ [128] 
 
Alignment of the primary structures corresponding to histone readers PHD fingers was 
carried out using the program Multalin, available on line at the website: 
http://multalin.toulouse.inra.fr/multalin/ [154] 
 
The detailed analysis on the stereochemistry of the protein structure was performed with 
PROCHECK programs. [155] 
 
The analysis of the solved structure and the preparation of the figures were done with the 
program PyMol (http://www.pymol.org/). 
114 
6.3 Results 
 
6.3.1 Biochemical and bioinformatics evidences for atORC1bPHD-BAH as 
H3K4Me0 reader 
 
Understanding the mechanisms employed by effector proteins to recognize specific histone 
codes and translate this information into a specific gene expression response represents a 
challenging goal in epigenetics. 
In this study we expressed and purified the fragment of Arabidopsis ORC1b (residue 126-
346) in yields sufficient for structural and function analysis. 
This specific construct was identified through a bioinformatic analysis of the full length 
sequence and chosen according to the presence of two adjacent chromatin associated motifs, 
a PHD (plant homeo domain) finger followed by a BAH (bromo adjacent homology) 
domain.  
A first approach for the analysis and prediction of the features of the PHD finger was carried 
out by comparing atORC1bPHD primary structure with other PHD fingers whose specificity 
for binding either methylated (me3) or unmethylated (me0) H3K4 was well established both 
biochemically and structurally. 
The multiple sequence alignment confirms that atORC1bPHD motif presents the classical 
Cys4-Hys-Cys3 pattern of the PHD finger fold (Fig. 6.4). [146] 
In addiction we can identify, within atORC1b PHD sequence, the specific signature that 
characterizes PHD fingers that recognize unmethylated H3K4. 
This pattern shows the presence of negatively charged amino acids (glutamic or aspartic 
acids, highlighted in the blue in the figure 6.4) preceding the canonical PHD finger, those 
acid residues have been proposed as key elements for recognition of unmodified H3K4. 
Another significant pattern for PHD fingers, able to “read” unmethylated H3K4, is the 
presence of two prolines intersperse between the 5
th
 and 6
th
 Cys that are supposed to force 
the conformation to a characteristic molecular architecture. 
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Conversely, the PHD fingers which recognize trimethylated H3K4, presents hydrophobic 
residues highlighted in violet in the figure 6.4, which are implied in trimethylated H3K4 
recognition.  
 
 
 
 
Fig. 6.4: Sequence alignment of PHD fingers of histone readers.  
Sequence comparison between the PHD finger of the atORC1b (fully evidenced in the 
schematic diagram of the protein) with other PHD fingers which recognize trimethylated or 
unmodified H3K4. Residues highlighted in red are implicated in the Cys4-Hys-Cys3 
coordination of the two zinc ions. The aspartate and glutamate highlighted in light blue are 
keys for recognition of unmodified H3K4.  
Residues highlighted in violet are implicated in trimethylated H3K4 recognition. 
 
To further confirm the affiliation of the whole PHD-BAH cassette and so devise the best 
crystallization screening, we performed ITC experiments. They allowed us to determine the 
dissociation constant (Kd) of the complex between the protein construct and the 
decapeptide, corresponding to H3 N-terminal tail, in different methylation states (K4me3, 2, 
1 and K4me0). (Fig. 6.5) We proved that PHD-BAH cassette shows a clear specificity for 
unmodified H3K4, binding the peptide with a Kd of 2.82 µM. We further asset that mono 
and di-methylation on epsilon amino group of lysine 4 entails an approximately 5 and 6-fold 
drop in binding affinity (14.9 µM for me1 and 17.2 for me2), respectively. 
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Finally, the binding affinity is totally cancelled for the three methylated lysine 4 (in this last 
case the dissociation constant is too weak to be measured accurately). 
According to this experiment, we concluded that PHD-BAH cassette is able to recognize the 
histone H3 N-terminal tail in vitro, evidencing a binding specificity for unmethylated versus 
methylated forms of the peptide. 
 
Fig. 6.5: Quantification of the binding affinity between atORC1bPHD-BAH and unmodified, 
mono-, di- and tri methylated H3K4 peptides (residues 1–10) by ITC. 
 
 
6.3.2 Structural basis of H3K4Me0 readout by atORC1b BAH-PHD 
 
The full-length Arabidopsis thaliana Orc1b protein proved to be difficult to crystallize.  
In order to understand the molecular basis of histone recognition, we attempted to crystallize 
the BAH-PHD cassette of atORC1b in complex with the unmodified histone H3(1-10) 
peptide. AtOrc1b protein fragment comprised of amino acids  produced crystals that 
diffracted to 1.9 Å. The structure of the protein-peptide complex was determined by 
anomalous dispersion with single-wavelength anomalous diffraction (SAD) method. The 
final Rwork was refined to 19.4 % and Rfree was 20.5 % (Table 6.1). The crystal belongs to 
P43 space group. The data statistic and structure refinement are shown below. 
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Data collection and processing   
Synchrotron, beamline NSLS-X29A 
Wavelenght (Å) 1.2827 
Space group P43 
Unit cell parameters a, b, c (Å) 64.4; 64.4; 79.6 
Resolution (Å) 50.0-1.9 (1.97-1.90) 
Unique reflections 25.599 
Redundancy 7.2 (7.4) 
Completeness (%) 99.8 (99.6) 
Rmerge (%) 9.2 (49.1) 
Average I/σ (I) 46.3 (5.1) 
Refinement   
R / Free R (%) 19.4 / 20.5 
RMSD from ideal geometry, lenght (Å) 0.003 
RMSD from ideal geometry, angles (°) 0.858 
Average B factor (Å)   
   Protein / peptide 40.8 / 39.1 
   Zn
2+
 61.2 
   Water 40.4 
Number of atoms 1,874 
   Protein / peptide  1,614 / 69 
   Zn
2+
 2 
   Water 189 
 
Table 6.1: Data collection, processing and refinement statistics. 
Values in parentheses are for highest-resolution shell. 
 
 
The refined structure has good stereochemical quality: all of the main chain ϕ/Ψ angles are 
located in the favourite region and none in the disallowed region of the Ramachandran plot, 
calculated by using PROCHECK as reported in the figure 6.6. 
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Fig. 6.6: The ensemble of backbone conformations of atORC1b displayed through the 
observed Ramachandran plot 
 
 
As predicted from the bioinformatic analysis of the protein sequence, the structure presents a 
canonical PHD finger (residues 162-215) defined by a ‘cross-braced’ topology and 
stabilized by a pair of coordinated zinc ions (Fig. 6.7.B). The PHD finger is composed by a 
pair of antiparallel beta-strands (b1: 180-183, b2: 187-191) flanked by two short α-helices 
(residues 192-194 and 210-214) and two long loops, unresolved. This PHD motif is 
followed by an additional BAH domain that delimits the N-terminal H3 binding site, in a 
specific molecular clamp that recognizes selectively the peptide substrate. This domain 
mainly consists of a series of antiparallel beta sheets and is reminiscent of a β barrel-like 
architecture. [152] 
In details this module is built up on a total of 14 antiparallel β strands arranged around a 
central core defined by four long antiparallel strands as evidences in figure 6.7.C. 
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This specific arrangement is similar to the first BAH domain solved by X-ray 
crystallography for saccharomyces cerevisiae ORC1 subunit (pdb code: 1M4Z), which is 
composed by 6 β-strands arranged around a core of four long antiparallel β sheets. [153] 
The decapeptide that mimicries H3K4 histone tail results partially contained in a short 
groove on the protein, marked by a prominent presence of negative charges (Fig. 6.8). 
 
Fig. 6.7: The molecular basis of H3(1-10)K4me0 recognition by atORC1b BAH-PHD. 
In PANEL A: Overall structure of atORC1bPHD-BAH bound to H3(1-10)K4me0 peptide. The 
PHD finger (green), the BAH domain (pink) and the bound H3K4me0 peptide (white) are 
shown in ribbon representation, respectively. 
In PANEL B: The cross-brace topology of the PHD domain is evidences and the residues 
involved in chelating Zn
2+
 are shown in stick representation. 
In PANEL C: The central core of the BAH domain is evidenced. 
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Fig. 6.8: Electrostatic surface representation of atORC1bPHD-BAH cassette. (blue positive 
charges, red negative ones). In the zoomed panel is highlighted how only N-terminal 
residues of H3 are caged inside the binding groove, defined by positive charges. 
 
 
The peptide does not adopt an extended β-strands conformation as was reported for the 
structures of H3K4Me0 reader AIRE complex (Fig. 6.10) (pdb code: 2KFT), [156]but, 
instead, it folds into a bent arrangement with a sharp turn of nearly 90 degree level with the 
peptide tyrosine 6. This constrained arrangement drives the three ARK residues on the 
outward surfaces of the BAH domain, leading the positive charged guanidinium group of H3 
arginine 8 to form a salt bridge with the carboxylates of the BAH residue aspartic acid 162 
placed on the external surface of the domain (Fig. 6.9). 
Distinct peptide foldings can be attributed to a substantial difference between the two 
binding sites. Indeed, for AIREPHD, the recognition of H3(1-10)K4Me0 fully occurs on the 
domain surface through the formation of antiparallel β sheets (Fig. 6.10) while for the 
atORC1b PHD-BAH cassette the binding site coincides with a well defined narrow groove 
that does not allows a plain insertion of the decapeptide. 
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Fig. 6.9: Positioning of H3(1–10) peptides on the external surface of atORC1b BAH-PHD 
cassette. The C terminal of the peptide is forced in a bent conformation through the 
formation of stabilizing charge charge interactions occurring between the R8 of the 
decapeptide and the D162 of the atORC1bPHD finger. 
 
 
 
 
Fig. 6.10: View of the association between human AIRE-PHD (296–367) and unmodified 
H3 (1-10).(PDB code: 2KFT) [156]. The peptide that mimicries the N-terminal histone 3 
(displayed as silver cartoon) interacts with the PHD domain through the formation of 
antiparallel β sheets. 
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As widely described in the literature, the first two charged residues of the H3 amino 
terminus are pivotal marks in defining the binding mode with histone readers. [133-135] 
In our structure atORC1bPHD-BAH accommodates the side chains of H3K4 and H3R2 
simultaneously in two different binding surfaces that are separated by the side chain of a 
glutamic acid 182, a residue involved in simultaneous binding with those crucial residues 
(Fig. 6.11). 
The side chain of H3K4 sits in narrow polar cage, where the unmodified lysine ε ammonium 
group of the side chain forms a direct hydrogen bonds with backbone carbonyl oxygen of 
L187 (Fig. 6.11). In addition, this group is anchored through a stabilizing electrostatic bridge 
with the carboxylate of highly conserved glutamic acids 167 and 182. 
 
Fig. 6.11:. Detailed view of the association between ORC1b BAH-PHD binding site and 
H3K4 in its unmethylated form. The width of the K4 binding site is evidenced. 
 
 
It is interesting to observe how all the residues involved in K4 binding belongs to the PHD 
finger, so a structural comparison with other similar PHD histone readers could be 
considered an effective strategy to reinforce the validness of the model. 
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This binding mode for K4 agrees with the recognition pattern of unmethylated lysine in the 
3D structures of other H3K4Me0 readers, AIREPHD (pdb code: 2KFT) [156] and BHC80PHD. 
[139] 
As well, in these complexes the side chain of H3K4 fits into a narrow channel defined by 
two polar residues (D297 and N295 for AIRE, D489 and E488 for BHC80). 
On reverse, the X-ray structures of methyl-lysine-binding PHD fingers such as BPTF (pdb 
code: 2F6J [150])  and ING2 (pdb code: 2VNF [151]) show that K4 side chain is buried by a 
wider full aromatic cage defined by tyrosines 10 and 17 and tryptophan 32 for BPTF (Fig. 
6.12) and tyrosines 216, 223 and tryptophan 239 for ING2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.12: Detailed interactions between human BPTF PHD domain (displayed in green) 
and H3K4 in its trimethylated form. (PDB code: 2F6J) 
The width of the K4 binding site is evidenced. 
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This structural model is consistent with the results obtained by the ITC assays which proved 
the selectivity of the ORC1b BAH-PHD cassette to H3K4(1-10)me0 and attested the 
impaired binding to mono- / di-methylated H3K4 peptide. 
An increasing methylation state at H3K4 would both create steric clashes with residues 
defining the narrow negative “cage” and disrupt the ionic interactions with D167 and 182 
and finally impair hydrogen bonding with L187 backbone. 
The considerations made on the three dimensional structure perfectly agree with the totally 
lack of binding affinity to trimethylated H3K4 peptide, as we demonstrated via ITC. 
The other positive charged residue, the H3R2, sits in a small pocket where the positive 
charged guanidinium forms hydrogen bond with the backbone carbonyls of G323 and A319 
and with the carboxylate group of glutamic acid 182 through a water molecule that 
simultaneously binds to the two charged side chains. (Fig. 6.13.A) 
The binding ability of R2 by histone readers is quite uncommon since in several 
crystallographic complexes this positive charged residue is oriented toward the solvent, 
without suggesting a prominent role in the protein-peptide recognition event. 
An exception is given by crystal structure of PHD finger of human AIRE complexed with 
H3(1-10)K4me0 peptide (pdb code: 2KFT), where the arginine 2 of the peptide is restrained 
via charge charge interactions with the D312 of the protein (Fig. 6.13.B). 
A concept which deserves to be emphasized is that, for the binding of arginine 2, both 
domains (PHD and BAH) are equally involved. This finding represents a new structural 
element in histone reader modules and further underlines the scientific relevance of 
combinatorial read out of the histone code by tandemly arranged reader modules. 
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Fig. 6.13: Detailed interactions between atORC1b BAH-PHD binding site and H3R2 
(PANEL A) and the analogous interactions between the H3R2 and the PHD finger of human 
AIRE (PANEL B) as was reported in corresponding  crystallographic model. (PDB code: 
2KFT) 
 
 
6.4 Conclusions 
 
The interplay between epigenetic reading domains within the same complex generates a 
multifaceted network of contacts and combinations that can elicit distinct biological 
outcomes. However only little information are known about the structural arrangement of 
multiple readers which recognize post transcriptional modification pattern on histone 
globular domains. In sum, we have proposed a pioneer 3D model which describes how two 
distinct histone-binder modules can be structural combined in order to reach a histone tail-
binding specificity. This remarkable result, sustained by calorimetric functional data, 
provides structural insights in the specific recognition of the decapeptide that mimicries the 
N-terminal tail of histone 3 and proposed atORC1bPHD-BAH as un-methylated histone 3 
reader. However, biochemical and cytological results, associated the H3K4Me with the 
active genes of euchromatin in Arabidopsis, combined with our structural insights of the 
recognition process are not enough to unambiguously define the role of ORC1b as silencing 
regulation factor (as often described for its evolutionary conserved non replication function). 
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Therefore further studies are needed to fully define the precise role of both ORC1b inside 
the dynamic network of chromatin remodelling factors in Arabidopsis organism, considering 
the possible recruitment of other silencing chromatin proteins. 
This open question is being currently evaluated by the group of Steven Jacobsen, at UCLA, 
which is collaborating with our structural biology group, through an extensive analysis of 
the interactions between transcription factors by means of ChiP. 
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Appendix A 
 
 Abbreviations and Symbols 
DNA Deoxyribonucleic acid 
RNA Ribonucleic acid 
PHD Plant homeo domain 
BAH Bromo adjacent homology domain 
ORC Origin recognition complex 
GMP Guanosine monophosphate  
G4 Guanosine quadruplex 
Gq Guanosine quadruplex 
PQS  Potential quadruplex sequences 
Bp Base pair 
HIV Human immunodeficiency virus 
SELEX  Systematic evolution of ligands by exponential enrichment 
FDA Food and drug administration 
AMD Age-related macular degeneration 
tRNA Transfer RNA 
PEG Polyethylene glycol 
PAR Platelet activate receptor 
Serpin Serine protease inhibitor 
HCII Heparin cofactor II 
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PNI Protease nexin I 
MW Molecular weight 
GAG Glycosaminoglycans 
ATIII Antithrombin III 
TBA Thrombin binding aptamer 
LWMH Low-molecular-weight heparin 
-mers Monomers 
NMR Nuclear magnetic resonance 
Tris Tris(hydroxymethyl)aminomethane 
EDTA Ethylenediaminetetraacetic acid 
CD Circular dichroism 
pNA Para-nitroaniline  
BSA Bovine serum albumin 
FRET Förster (Fluorescence) resonance energy transfer 
Tm Melting temperature 
FAM Carboxyfluorescein 
DABCYL 4 - ((4 - (dimethylamino)phenyl)azo)benzoic acid 
HPLC High-performance liquid chromatography 
UV Ultraviolet 
Mol. Elip. Mean residue ellipticity  
nt Nucleotides 
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SDS Sodium Dodecyl Sulphate  
PAGE  PolyAcrylamide Gel Electrophoresis 
LB Luria Bertani 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
DTT Dithiothreitol 
Da Dalton 
Aa Amino acid 
Å Amstrong 
UFH Unfractionated heparin  
EMSA Electromobility Shift assay 
GSH Glutathione 
IEC Ion exchange chromatography  
FF Fast flow 
MWCO Molecular weight cut off 
FPLC Fast protein liquid chromatography 
NHE Nuclease hypersensitive element 
CNBP Cellular nucleic acid-binding protein 
RBD RNA binding domain 
RRM  RNA recognition motif 
rRNA Ribosomal ribonucleic acid 
mRNA Messanger ribonucleic acid 
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SUMO Small Ubiquitin-like Modifier 
cDNA  Complementary DNA 
PCR Polymerase chain reaction 
OD Optical density 
PMSF Phenylmethylsulphonyl fluoride  
β-ME β-mercaptoethanol  
IMAC Immobilized metal affinity chromatography  
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
ITC Isothermal titration calorimetry 
Ulp Ubl-specific protease  
ADP Adenosine diphosphate 
ChiP Chromatin Immunoprecipitation 
BHC80 BRAF-HDAC complex 
Mcm Mini chromosome maintenance proteins  
CDC Cell division cycle 
pre-RC Pre-replication complexes 
Sir1 Silence information regulator 1 
HP1 Heterochromatin protein 1 
RING Really Interesting New Gene 
PC Polycomb-like protein 
AIRE Autoimmune regulator 
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BPFT Bromodomain PHD finger transcription 
ING2 Inhibitor of growth family 2 
LSD1 Lysine-specific histone demethylase 1 
GST Glutatione S-transferase 
HER3 Human Epidermal Growth Factor Receptor 
HIF Hypoxia-inducible factors 
Rb Retinoblastoma protein 
BCL-2 B lymphocyte chemoattractant  
VEGF Vascular endothelial growth factor 
N-Ras Rat sarcoma 
RET Rearranged during transfection 
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Amino acid abbreviations 
 
 
 
 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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Appendix B 
 
Protein primary structures and numbering schemes 
 
 
Human thrombin, A chain (uniProtKB code: P00734) 
 
        10         20         30     36 
TFGSGEADCG LRPLFEKKSL EDKTERELLE SYIDGR 
 
 
 
 
Human thrombin, B chain (uniProtKB code: P00734) 
 
 
        10         20         30         40         50         60  
IVEGSDAEIG MSPWQVMLFR KSPQELLCGA SLISDRWVLT AAHCLLYPPW DKNFTENDLL  
 
        70         80         90        100        110        120  
VRIGKHSRTR YERNIEKISM LEKIYIHPRY NWRENLDRDI ALMKLKKPVA FSDYIHPVCL  
 
       130        140        150        160        170        180  
PDRETAASLL QAGYKGRVTG WGNLKETWTA NVGKGQPSVL QVVNLPIVER PVCKDSTRIR  
 
       190        200        210        220        230        240  
ITDNMFCAGY KPDEGKRGDA CEGDSGGPFV MKSPFNNRWY QMGIVSWGEG CDRDGKYGFY  
 
       250       259 
THVFRLKKWI QKVIDQFGE 
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Human nucleolin (uniProtKB code: P19338) 
 
        10         20         30         40         50         60  
MVKLAKAGKN QGDPKKMAPP PKEVEEDSED EEMSEDEEDD SSGEEVVIPQ KKGKKAAATS  
 
        70         80         90        100        110        120  
AKKVVVSPTK KVAVATPAKK AAVTPGKKAA ATPAKKTVTP AKAVTTPGKK GATPGKALVA  
 
       130        140        150        160        170        180  
TPGKKGAAIP AKGAKNGKNA KKEDSDEEED DDSEEDEEDD EDEDEDEDEI EPAAMKAAAA  
 
       190        200        210        220        230        240  
APASEDEDDE DDEDDEDDDD DEEDDSEEEA METTPAKGKK AAKVVPVKAK NVAEDEDEEE  
 
       250        260        270        280        290        300  
DDEDEDDDDD EDDEDDDDED DEEEEEEEEE EPVKEAPGKR KKEMAKQKAA PEAKKQKVEG  
 
       310        320        330        340        350        360  
TEPTTAFNLF VGNLNFNKSA PELKTGISDV FAKNDLAVVD VRIGMTRKFG YVDFESAEDL  
 
       370        380        390        400        410        420  
EKALELTGLK VFGNEIKLEK PKGKDSKKER DARTLLAKNL PYKVTQDELK EVFEDAAEIR  
 
       430        440        450        460        470        480  
LVSKDGKSKG IAYIEFKTEA DAEKTFEEKQ GTEIDGRSIS LYYTGEKGQN QDYRGGKNST  
 
       490        500        510        520        530        540  
WSGESKTLVL SNLSYSATEE TLQEVFEKAT FIKVPQNQNG KSKGYAFIEF ASFEDAKEAL  
 
       550        560        570        580        590        600  
NSCNKREIEG RAIRLELQGP RGSPNARSQP SKTLFVKGLS EDTTEETLKE SFDGSVRARI  
 
       610        620        630        640        650        660  
VTDRETGSSK GFGFVDFNSE EDAKAAKEAM EDGEIDGNKV TLDWAKPKGE GGFGGRGGGR  
 
       670        680        690        700        710  
GGFGGRGGGR GGRGGFGGRG RGGFGGRGGF RGGRGGGGDH KPQGKKTKFE  
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Arabidopsis thaliana origin recognition complex 1b (uniProtKB code: Q9SU24) 
 
 
        10         20         30         40         50         60  
MASTPRAKTF KSPTKTPSNI YRKSYLSPSS TSHTPQTPET HTPLRRSARH VSRKIDLGND  
 
        70         80         90        100        110        120  
PIDAPGNDPI EGMNLIRKRE RAPRKPTTDV VPSKSKKTET PKKKKKIDSF TPVSPIRSET  
 
       130        140        150        160        170        180  
IKKTKKKKRV YYNKVEFDET EFEIGDDVYV KRREDSNSDE EEDPEIEDCQ ICFKSDTNIM  
 
       190        200        210        220        230        240  
IECDDCLGGF HLKCLKPPLK EVPEGDWICQ FCEVKKSGQS QTLDLPKPPE GKKLARTMRE  
 
       250        260        270        280        290        300  
KLLSGDLWAA RIDKLWKEVD DGVYWIRARW YMIPEETVSG RQPHNLKREL YLTNDFADIE  
 
       310        320        330        340        350        360  
MECILRHCSV KCPKEFSKAS NDGDDVFLCE YEYDVHWRSF KRLAELADGD SDSDQEWNGR  
 
       370        380        390        400        410        420  
KEEEVDDSDE EMELDDEVLK SKRGGLTSAR GGANSRKGRF FGVEKVGMKL IPEHVRCHKQ  
 
       430        440        450        460        470        480  
SELEKAKATL LLATRPKSLP CRSKEMEEIT SFIKGSISDD QCLGRCMYIH GVPGTGKTIS  
 
       490        500        510        520        530        540  
VLSVMKNLKA EVEEGSVSPY CFVEINGLKL ASPENIYSVI YEALSGHRVG WKKALQCLNE  
 
       550        560        570        580        590        600  
RFAEGKRIGK EDEKPCILLI DELDLLVTRN QSVLYNILDW PTKPNSKLVV LGIANTMDLP  
 
       610        620        630        640        650        660  
EKLLPRISSR MGIQRLCFGP YNHTQLQEII STRLNGIDAF EKTAIEFASR KVAAISGDAR  
 
       670        680        690        700        710        720  
RALEICRRAA EVADHRLNTN KSAKNQLVIM ADVEAAIQEM FQAPHIQVMK SVSKLSKIFL  
 
       730        740        750        760        770        780  
TAMVHELYKT GMAETTFDRV ATTVSSICLT NGEAFPGWDI LLKIGCDLGE CRIILCEPGE  
 
       790        800        810 813 
KHRLQKLQLN FPSDDVAFAL KDNKDLPWLA NYL 
 
 
The protein primary structures were found in the UniProtKB databases 
(http://www.uniprot.org/help/uniprotkb), a widely used hub for the collection of protein 
informations. The numbering scheme was assigned by using the ProtParam web-server 
tool.(http://web.expasy.org/protparam/) 
